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Functional food products consist of a modified foodstuff that can provide additional health 
and well-being benefits beyond their basic nutrition. In vitro and in vivo studies have reported 
that conjugated linolenic acid (CLNA) exerts anti-inflammatory, anti-cancer, anti-obesity and 
antioxidant activities. This group of conjugated isomers is naturally present in vegetable oils 
and ruminant meat and milk fat, however, lactobacilli, bifidobacteria and propionibacteria 
strains have revealed the capacity to produce CLNA isomers. Thus, the aim of this work was 
to identify CLNA producing strains, among a total of 12 Lactobacillus and 3 Bifidobacterium 
strains, that could be applied in the future formulation of new functional food products. 
CLA and CLNA microbial producing ability have been related to the presence of the 
linoleate isomerase (LAI) gene. Therefore, after the optimization of bacterial growth 
conditions, it was performed a molecular detection assay of LAI gene 
in Lactobacillus strains. Lactobacillus brevis D24, Lactobacillus plantarum D36 
and Lactobacillus plantarum 299v revealed a positive result for the presence of LAI gene. 
In order to test strains for their CLNA producing ability, selected strains were first tested 
for their capacity to produce CLA isomers given previous evidence, experimental knowledge 
and chemical similarity with CLNA group of isomers. Low concentrations of CLA were 
detected, even for the positive LAI gene strains, although LA reduction rate was considerably 
high. Two strategies were then applied in order to optimize CLA production: addition of LA 
to the pre-inocula and inocula and addition of LA after 7 h of incubation. Despite the efforts, 
CLA production continued to be low in comparison to the percentages of LA reduction. LA 
was detected in strains’ pellet fatty acid composition, suggesting that the substrate could be 
being incorporated in the membrane. The amount of LA absorbed did not correspond to the 
level of substrate that was reduced, therefore, it was concluded that LA must have been 
converted into other unexpected compounds through an alternative transformation pathway 
not yet described. 
Among the strains tested, B. breve NCIMB 702258 was the only strain to demonstrate 
CLA-producing capacity. Further assays showed that this strain was also able to convert       
-LNA into CLNA isomers, even in a food matrix (1.6% reduced-fat milk). Therefore, B. 
breve NCIMB 702258 has the potential to be applied in the elaboration of CLA and CLNA 










Os alimentos funcionais consistem em géneros alimentícios modificados capazes de 
providenciar benefícios adicionais para a saúde e bem-estar além da sua nutrição básica. 
Estudos in vitro e in vivo revelaram que o ácido linolénico conjugado (CLNA) exerce 
actividades anti-inflamatória, anti-cancerígena, anti-obesidade e antioxidante. Este grupo de 
isómeros conjugados está naturalmente presente em óleos vegetais e na gordura da carne e 
leite de ruminantes, contudo, estirpes dos géneros lactobacilli, bifidobacteria e 
propionibacteria têm demonstrado capacidade para produzirem isómeros de CLNA. Assim, o 
objectivo deste trabalho foi de se identificar estirpes produtoras de CLNA, entre um total de 
12 estirpes Lactobacillus e 3 Bifidobacterium, que possam vir a ser aplicadas na formulação 
futura de novos produtos funcionais. 
A capacidade de produção de CLA e CLNA tem sido relacionada com a presença do gene 
da linoleato isomerase (LAI). Por isso, após a optimização das condições de crescimento, foi 
realizado um ensaio de detecção molecular do gene LAI em estirpes do género Lactobacillus. 
Lactobacillus brevis D24, Lactobacillus plantarum D36 e Lactobacillus plantarum 299v 
deram resultado positivo relativamente à presença do gene LAI. 
De forma a se testar a capacidade de produção de CLNA das estirpes, estirpes 
seleccionadas foram primeiro testadas quanto à sua capacidade de formação de isómeros de 
CLA dadas anteriores evidências, o conhecimento experimental e a similaridade química com 
o grupo de isómeros de CLNA. Baixas concentrações de CLA foram detectadas, mesmo para 
as estirpes com o gene LAI presente, embora as taxas de redução do LA tenham sido 
consideravelmente altas. Duas estratégias foram então depois tomadas de forma a se optimizar 
a produção de CLA: adição de LA aos pre-inóculos e inóculos e adição de LA após 7 h de 
incubação. Apesar das tentativas, a produção de CLA continuou a ser baixa comparando com 
a percentagem de redução do LA. Na composição de ácidos gordos do pellet das estirpes, foi 
detectada a presença de LA, o que sugeriu que o substrato pudesse estar sendo incorporado na 
membrana. A quantidade de LA absorvida não correspondia ao nível de substrato que foi 
reduzido, por isso foi concluído que o LA teria que estar a ser convertido em outros 
compostos não esperados através de uma via de transformação alternativa ainda não descrita. 
Entre as estirpes testadas, B. breve NCIMB 702258 foi a única que demonstrou a 
capacidade de produção de CLA. Ensaios posteriores revelaram que esta estirpe também era 
capaz de converter -LNA em isómeros de CLNA, mesmo numa matriz alimentar (leite meio 
gordo). Assim sendo, B. breve NCIMB 702258 tem o potencial para ser aplicada na 
elaboração de produtos enriquecidos em CLA e CLNA, contudo, as características 
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This dissertation is divided in five parts. In the first part it is presented a state of the art 
regarding CLNA isomers bioactivity, natural sources, enhancement strategies in food, 
microbiological production, molecular screening tools and stability in enriched products. In 
the second part it is explained how this work was carried out in order to accomplish the goals 
intended. The third part shows the results obtained during this research effort along with the 
discussion of those results. The main conclusions achieved with this work are presented in the 
fourth part while the fifth refers the research work that could be performed in the future in 
order to consolidate the new information accomplished with this study. 
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Cardiovascular diseases (CVD), like ischemic heart disease and stroke, are the leading 
worldwide death causes, being responsible for 17 million deaths in 2008 (Alwan, 2011). 
Overweight and obesity are the major risk factors for cardiovascular diseases, and it was 
estimated that between 1980 and 2008 the prevalence of overweight and obese adults (≥20 
years old) increased from 24.6% to 34.4% and from 6.4% to 12.0%, respectively (Stevens et 
al., 2012). Although lipids are involved in the development of these conditions, recent studies 
have also stated their positive health effects on humans. Thus, dietary sources of omega 3 
have shown to be capable of reducing the incidence of CVD, through decreasing the number 
of sudden deaths as well as the effect of risk factors such as obesity, hypertension and 
cholesterol (Harris, 2008). Furthermore, the bioactivity of conjugated linoleic acid (CLA) has 
been well characterized, namely for its anticarcinogenic, antiobese, antidiabetic and 
antihypertensive properties effects (Koba and Yanagita, 2014). However, CLA is not the only 
group of bioactive conjugated fatty acids and recently conjugated linolenic acid (CLNA) have 
also shown bioactive potential as anti-carcinogenic, anti-inflammatory, anti-obese and 
antioxidant compounds (Yuan et al., 2014) being a promising new bioactive ingredient. Thus, 
this chapter aims to summarize the evidences about the beneficial health effects of CLNA and 
the possibilities of their utilization in new functional foodstuffs thus establishing the rationale 
for the research project developed herein.  
 
1.1. CLNA bioactivity 
 
1.1.1. Anti-cancer activity 
 
Some studies have reported the cytotoxic effect of CLNA isomers on different human 
tumor cell lines, including MDA-MB-231, MCF-7 (breast) (Moon et al., 2010), HT-29 
(colon) (Degen et al., 2011), MDA-MB-231 (estrogen insensitive breast cancer cells), MDA-
ER7 (estrogen sensitive breast cancer cells cloned from MDA-MB-231 cells) (Grossmann et 
al., 2010), T24 (bladder) (Sun et al., 2012), HeLa (cervix) (Eom et al., 2010), LNCaP, PC-3 
(prostate) (Gasmi and Sanderson, 2013) and DLD-1 (colorectal)  (Shinohara et al., 2012b). 
The works found that the anti-proliferative activity was due to an increment in the number of 




to proliferate) and the increase of apoptosis rate are the main anti-cancer activity evidences 
verified for CLNA isomers. 
These activities seem to be influenced by the configuration of the double bonds.  Degen et 
al. (2011), when evaluating growth inhibition effects of pure CLNA isomers against HT-29 
colon cancer cells, found that in the presence of an all-trans isomer, as C18:3 t9,t11,t13 
resulted in greater inhibition than with C18:3 c9,t11,t13. Furthermore, Shinohara et al. 
(2012b) assaying the cytotoxic effects of several pure CLNA isomers from vegetable sources 
on DLD-1 colorectal cancer cells, observed that jacaric acid (JA) (C18:3 c8,t10,c12) exerted a 
stronger effect in terms of decreasing cell survival and inducing apoptosis when compared 
with -eleostearic acid (-ESA) (C18:3 c9,t11,t13), punicic acid (PUA) (C18:3 c9,t11,c13), 
catalpic acid (CPA) (C18:3 t9,t11,c13) and the trans-isomers -eleostearic acid (-ESA) 
(C18:3 t9,t11,t13) and -calendic acid (-CDA) (C18:3 t8,t10,t12), all tested at the same 
concentration (10 µM). Further studies partially confirmed these previous results since when 
pure JA, PUA, -CDA and -CDA cytotoxicity was investigated against LNCaP and PC-3 
prostate cancer cells results pointed out to PUA and JA as the most effective (Gasmi and 
Sanderson, 2013). At the time PUA and JA 3-D conformations were analyzed and overlapped, 
shape and feature similarity values were highly correlated, indicating that the cis, trans, cis 
configuration of their double bonds is the reason of their bioactivity. 
It has also been suggested that the mechanism of CLNA anti-cancer activity may be 
related to lipid peroxidation, since the addition of -tocotrienol, an antioxidant, lead to the 
loss of PUA cytotoxic properties against MDA-MB-231 and MDA-ER7 breast cancer cells 
(Grossmann et al., 2010). These authors also associated the CLNA´s cytotoxicity to the 
induction of protein kinase C (PKC) that leads to the inhibition of cell proliferation and 
activation of apoptosis. Other studies have reported increase of caspase-3 expression, decrease 
of apoptosis suppression factor Bcl-2 expression, formation of reactive oxygen species 
(ROS), activation of caspase-9 cascade, DNA fragmentation, poly ADP-ribose polymerase 
(PARP) cleavage, increase of tumor suppressor gene p53 expression, activation of 
peroxisome proliferator-activated receptor gamma (PPAR) and inhibition of extracellular 
signal-regulated kinases 1 and 2 (ERK 1/2) (Sun et al., 2012; Moon et al., 2010). 
CLNA anti-carcinogenic activity has also been assayed in vivo, mainly with natural plant 
sources. Tung oil, which is rich in -ESA, when administered at doses of 50 and 100 mg/kg 
body to mice transplanted with DLD-1 colorectal cancer cells, suppressed vessel formation: in 




mg/kg body weight (Tsuzuki and Kawakami, 2008). Bitter gourd seed oil (rich in -ESA) was 
also able to inhibit aberrant crypt foci (ACF) formation, induced by azoxymethane (AOM), in 
rats fed with at 0.01, 0.1 and 1% (Kohno et al., 2002). Furthermore, feeding mice treated with 
nitrobenzene, a genotoxic inductor, with 100, 200 and 400 mg/kg body weight of 
pomegranate seed oil (PUA rich source), caused a significant reduction in the percentage of 
aberrant cells and sperm shape and chromosome aberrations (Aly et al., 2014). When 
pomegranate seed oil was administered to rats, this led to a significant suppression of 
adenocarcinomas incidence and multiplicity in colon. Most of the studies described above 
have associated CLNA cytotoxicity in vivo to enhanced PPAR expression. CLNA anti-
cancer properties could also be due to the metabolic conversion of CLNA to CLA, since lipid 
analysis in liver and colon of rats fed with pomegranate seed oil did not detect CLNA 
isomers, but CLA content was elevated in a dose-dependent manner (Kohno et al., 2004). 
When compared to CLA, -ESA suppressed tumor vessel formation at doses 10 times lower 
(Tsuzuki and Kawakami, 2008) supporting the fact that CLNA isomers could exert a more 
powerful bioactivity than CLA. 
However, despite these promising results no studies focusing on CLNA anti-cancer 
properties have been carried out on human subjects so far. 
 
1.1.2. Anti-inflammatory activity 
 
Cells (e.g. neutrophils, macrophages and monocytes) and biochemical compounds, like 
tumor necrosis factor (TNF-), interleukins (IL), platelet activating factor (PAF), leukotrienes 
and ROS are involved in inflammatory diseases. Therefore, an increment of these mediators is 
an indicator of ongoing inflammation. 
Anti-inflammatory activity of CLNA in vitro has only been reported for PUA on human 
breast cancer cells (MDA-MB-231 and MCF-7) in the presence of pomegranate seed oil for 
24 h at 37 ºC (Costantini et al., 2014). The levels of 9 pro-inflammatory cytokines, including 
ILs and TNF-, were significantly decreased at amounts ranging from 0.24 to 0.6 µL. 
Necrotising enterocolitis (NEC) is characterized pathologically by inflammatory and 
coagulative necrosis that occurs throughout the intestinal tract of, especially, newborns. 
Pomegranate seed oil administration at 1.5% to NEC rats caused significant reduction on ileal 
damage while expression levels of IL-6, IL-8, IL-12, IL-23 and TNF- mRNA were 




On the other hand, inflammatory bowel disease (IBD) is a chronic inflammatory disease 
that can manifest itself as ulcerative colitis (affects only the large intestine) or Crohn’s disease 
(affects the whole digestive tract). -ESA was shown to be able to ameliorate IBD 
phenotypes when incorporated in induced-IBD mice diet, through equally PPAR-dependent 
and independent mechanisms (Lewis et al., 2011). Both -ESA and PUA, were also capable 
to significantly reduce IL-6, Il-1 and TNF- expressions in rats treated with sodium arsenite 
and streptozotocin (Saha et al., 2012b; Saha and Ghosh, 2012). According to Saha and Ghosh 
(2011), high concentrations of arachidonic acid (ARA: C20:4 ,c8,c11,c13,c16) together with 
low levels of -linolenic acid (γ-LNA: C18:3 c6,c9,c12) in tissues are indicators of 
inflammation. Vegetable oils containing -ESA or PUA were capable of normalizing ARA 
and γ-LNA amounts in rats when an inflammatory process altered their concentrations. 
Both in vitro and in vivo studies, suggest that CLNA can interfere with inflammation 
mediators. At the current moment the anti-inflammatory effects of CLNA have not been 
tested on humans. 
 
1.1.3. Antioxidant activity 
 
Some works have also reported antioxidant properties for CLNA. Karela seed oil (rich in 
-ESA) was added at 0.05 and 0.1% to human blood samples of diabetic and non-diabetic 
subjects reducing lipid peroxidation at both doses in samples from diabetic subjects (Dhar et 
al., 2007). Other assays comparing bitter (-ESA) and snake (PUA) gourd seed oils revealed 
that the antioxidant activity was greater for bitter gourd seed oil, possibly due to -ESA’s 
better oxidative stability (Saha et al., 2012c), since trans double bonds are more stable than 
cis. 
Some in vivo studies have been carried out to test the activity of CLNA isomers against 
chemically-induced oxidative stress. As in the in vitro research works mentioned above, -
ESA and PUA showed antioxidant properties in rats treated with sodium arsenite to induce 
oxidative stress being -ESA the most effective at the lowest dose since it was able to 
increase the activity of antioxidant enzymes (SOD, CAT and GPx) and glutathione (GSH) 
levels while it decreased nitric oxide synthase (NOS) activity and lipid and protein oxidation 
in plasma and kidney (Saha and Ghosh, 2013). Some of these effects were also observed with 
-ESA against the oxidative stress caused by methyl mercury and induced diabetes in rats 




On the other hand, the effect of PUA was tested on 15 healthy young humans, consuming 
an equivalent of 3 g/day of PUA from Trichossanthes kirilowii seeds during 28 days (Yuan et 
al., 2009); results concluded that PUA exhibited a pro-oxidant activity. These findings seem 
to be controversial with the in vivo studies described above, however, animal studies revealed 
that PUA has both antioxidant and pro-oxidant activity depending on the dose used: feeding 
rats with an equivalent of 0.6 g/kg of PUA lead to antioxidant effects, whereas a higher dose 
of 1.2 g/kg caused pro-oxidant activity (Mukherjee et al., 2002).  
 
1.1.4. Anti-obesity activity 
 
CLA isomers have been described to exert positives effects on body weight and due to the 
similarities among these fatty acids, some works have been focused on the study of the 
possible anti-obesity properties of CLNA. When 3T3-L1 adipose cells were exposed to a 
mixture of two CLNA isomers: RLA and C18:3 c9,t13,c15 at 10 and 100 µM triacyglycerol 
content decreased at both concentrations (Miranda et al., 2011). However, a dose of 10 µM 
increased the expression of hormone-sensitive lipase (HSL) while 100 µM affected adipose 
triglyceride lipase (ATL).  
Moreover, oral administration of -ESA and PUA, caused decrease of triacylglycerol 
(TAG), cholesterol and LDL-C levels and increase of HDL-C level in plasma, erythrocytes, 
liver and brain of obese and hypercholesterolemic rats (Saha et al., 2012a; Sengupta et al., 
2015). Although no significant weight loss was observed, body weight gain and fat mass were 
reduced. Interestingly, the activity of HMG-CoA reductase, responsible for cholesterol 
biosynthesis, was found to decrease. Authors concluded that -ESA was more effective than 
PUA and associated such effects to the trans configuration of this fatty acid.  
It has been elsewhere suggested that effects of CLNA on lipolysis are due to the activation 
of cAMP-activated protein kinase (PKA) pathway and apoptosis in white adipose tissue 
(Chen et al., 2012). Nevertheless, the administration of JA (5 mg/day) for 1 week to normal 
rats increased the accumulation of palmitic acid (C16:0) and stearic acid (C18:0) while 
decreasing palmitoleic acid (C16:1 c9) and oleic acid (C18:1 c9) in liver and white adipose 
tissues (Shinohara et al., 2012a). The results were associated to the inhibition of stearoyl 
coenzyme A desaturase (SCD) activity, an endoplasmic reticulum enzyme that catalyzes the 
biosynthesis of monounsaturated fatty acids (MUFAs) from saturated fatty acids (SFAs), 




Recently a study was carried out with humans. The effect of pomegranate seed oil, was 
investigated by monitoring lipid profile of 23 volunteer hyperlipidaemic subjects (<20 yr) 
enrolled in a parallel, randomized, double-blind and placebo-controlled study (Mirmiran et 
al., 2010). The test group consumed one capsule containing 400 mg of seed oil twice a day 
during 4 weeks. The results revealed a significantly decrease in TAG and TAG:HDL-C ratio 
levels although cholesterol and LDL-C levels remained unchanged.  
According to the already reported research works, there are strong evidences supporting 
the bioactivity of CLNA isomers (mainly -ESA and PUA) and their potential to be used as a 
functional ingredient. However, little research has been performed on humans. Thus, to fully 
understand the mechanisms and possibilities of these compounds more investigations focused 
on this topic need to be accomplished.  
 
1.2. CLNA in foods: main sources and contents 
 
It has been reported that CLNA isomers occur naturally in milk fat and meat of ruminants, 
however, it is mostly found in vegetable oils (Mapiye et al., 2013) (Table 1.1). Despite all the 
possible isomers, only seven compounds are found in plant seed oils: jacaric acid (JA) (C18:3 
c8,t10,c12), -eleostearic acid (-ESA) (C18:3 c9,t11,t13), -eleostearic acid (-ESA) 
(C18:3 t9,t11,t13), punicic acid (PUA) (C18:3 c9,t11,c13), -calendic acid (-CDA) (C18:3 
t8,t10,c12), -calendic acid (-CDA) (C18:3 t8,t10,t12) and catalpic acid (CPA) (C18:3 
t9,t11,c13) (Tanaka et al., 2011). The main source of JA is the seed oil of the argentine native 
tree Jacaranda mimosifolia, with 36 g/100 g of oil (Kraus et al., 2005). The isomer -ESA is 
the main compound of tung oil (Aleurites fordii) (70 g/100 g of oil), a native tree from 
Southeast Asia and the Pacific Islands (Burrows and Tyrl, 2013), bitter melon (Momordica 
charantia) (50 g/100 g of oil) (Dhar et al., 1999) and Parinarium spp. (60 g/100 g of oil) 
(Scrimgeour and Harwood, 2007). This isomer can be found in white mahlab (Prunus 
mahaleb) (40 g/100 g of oil), a small tree native to southern Europe that grows wild in the 
Mediterranean region across to Turkey (Sbihi et al., 2014).  
Tung and bitter melon seeds also contain -ESA but in lower concentrations (3.5 and 2.6 
mol/100 mol of oil, respectively) than those of -ESA (Tsuzuki et al., 2004). PUA is mainly 
found in pomegranate (Punica granatum) (70 g/100 g of oil) (Spilmont et al., 2013) and 
balsam apple (Momordica balsamina) (50 g/100 g of oil) (Gaydou et al., 1987), while snake 




g/100 g of oil and above 30 g/100 g of oil, respectively (Yang et al., 2012). Trichosanthes 
anguina is a native vine from tropical Asia and it is cultivated in China, while Trichosanthes 
kirilowii is distributed through several Chinese provinces and also occurs in Korea and Japan 
(Hu, 2005). In pot marigold (Calendula officinalis) it is possible to find -CDA (>50 g/100 g 
of oil) and a small amount of -CDA (<1 g/100 g of oil) (Dulf et al., 2013). CPA is mainly 
present in Catalpa ovata (40 g/100 g of oil), a species originating in China (Suzuki et al., 
2006). Among the seeds that contain CLNA isomers, only those from pomegranate, snake 
gourd T. kirilowii and white mahlab are edible. Pomegranate is native form Persia and 
cultivated in Mediterranean countries, Afghanistan, India, China, Japan, Russia and some 
parts of the United States. Its edible parts are comprised of 80% juice and 20% seeds, also 
used to produce fresh juice, syrups, canned beverages, jelly, jam and for flavouring drinks 
(Fadavi et al., 2006). Trichosanthes kirilowii seeds have long been used as a traditional 
Chinese medicine to reduce infections and are a popular snack food in China (Yuan et al., 
2014). White mahlab powder is used in Greece, Cyprus, Turkey and neighboring Arab 
countries from Syria to Saudi Arabia for flavouring breads and pastries while in Sudan it is 
also used as a medicine for diarrhea in children (Ieri et al., 2012). 
The isomers C18:3 c9,t11,c15 (Rumelenic acid, RLA) and C18:3 c9,t11,t15 have been 
described as the main CLNA isomers in milk fat and meat of ruminants. In bovine milk, RLA 
has been detected at concentrations between 0.03 and 0.39 g/100 g of fat and C18:3 c9,t11,t15 
between 0.02 and 0.06 g/100 g of fat (Lerch et al., 2012; Plourde et al., 2007b). Relatively to 
ruminant meat, RLA and C18:3 c9,t11,t15 isomers, were found in steer (0.08 and 0.02 mg/g, 
respectively), cow (0.06 and 0.02 mg/g, respectively) and goat (0.28 and 0.03 g/100 g of meat 
fat, respectively) (Ebrahimi et al., 2014; Mapiye et al., 2013; Nassu et al., 2011). In 
comparison to the vegetable oils, the concentration of CLNA in these foodstuffs is very low, 
which suggests that the intake of CLNA, in order to highlight its potential health benefits, 
would not be viable through this natural source, therefore, strategies to enhance its intake will 










Source Amount Reference 
Jacaric acid (JA) C18:3 c8,t10,c12 Jacaranda mimosifolia seed oil 36 g/100 g of oil Tulloch, 1982 
-eleostearic acid (-ESA) C18:3 c9,t11,t13 
Aleurites fordii seed oil >70 g/100 g of oil Tsuzuki et al., 2006 
Momordica charantia seed oil >50 g/100 g of oil Dhar et al., 1999 
Parinarium spp. seed oil >60 g/100 g of oil 
Scrimgeour and Harwood, 
2007 
Prunus mahaleb seed oil 40 g/100 g of oil Sbihi et al., 2014 
-eleostearic acid (-ESA) C18:3 t9,t11,t13 
Aleurites fordii seed oil 3.5 mol/100 mol of oil Tsuzuki et al., 2004 
Momordica charantia seed oil 2.6 mol/100 mol of oil Tsuzuki et al., 2004 
Punicic acid (PUA) C18:3 c9,t11,c13 
Punica granatum seed oil >70 g/100 g of oil Spilmont et al., 2013 
Momordica balsamina seed oil 50 g/100 g of oil Gaydou et al., 1987 
Trichosanthes anguina seed oil 40 g/100 g of oil Mukherjee et al., 2002 
Trichosanthes kirilowii seed oil >30 g/100 g of oil Yang et al., 2012 
-calendic acid (-CDA) C18:3 t8,t10,c12 Calendula officinalis seed oil >50 g/100 g of oil Dulf et al., 2013 
-calendic acid (-CDA) C18:3 t8,t10,t12 Calendula officinallis seed oil <1 g/100 g of oil Dulf et al., 2013 
Catalpic acid (CPA) C18:3 t9,t11,c13 Catalpa ovate seed oil >40 g/100 g of oil Suzuki et al., 2006 
Rumelenic acid C18:3 c9,t11,c15 
Bovine milk 0.03-0.39 g/100 g of fat 
Lerch et al., 2012; Plourde et 
al., 2007a 
Bovine meat 0.06-0.08 mg/g of muscle 
Mapiye et al., 2013; Nassu et 
al., 2011 
Goat meat 0.28 g/100 g of meat fat Ebrahimi et al., 2014 
 C18:3 c9,t11,t15 
Bovine milk 0.02-0.06 mg/100 g of fat Lerch et al., 2012 
Bovine meat 0.02 mg/g of muscle 
Mapiye et al., 2013; Nassu et 
al., 2011 




1.3. Strategies for CLNA enhancement in food 
 
It is accepted that the effective dose of CLA to obtain the beneficial effects in humans is 3 
g/day (Ip et al., 1994) and for CLNA 2-3 g/day (Shinohara et al., 2012b). However, both 
values were assumed based on animal models. Specifically, the CLNA dose was calculated 
from the amount of jacaranda seed oil administered to mice (0.001 g/day), exerting anti-
cancer properties against transplanted human colorectal adenocarcinoma cells. Since it is a 
value obtained from animal studies, it cannot be completely assumed as the correct effective 
dose for humans as our metabolism and absorption of nutrients is different from that in 
animals. 
Furthermore, obtaining this amount from milk and meat of ruminants, would be difficult 
according to the concentration of CLNA in these foodstuffs. On the other hand, the vegetable 
oils may be an alternative but currently pomegranate seed oil is the only edible oil that is 
commercialized. When this vegetable oil was administered to hyperlipidaemic subjects, no 
side effects were reported, however, the dose administered (0.80 g/day of oil that is equivalent 
to 0.56 g/day of PUA) is much lower than the abovementioned effective dose (Mirmiran et 
al., 2010). Moreover, pomegranate seed oil has been successfully incorporated in margarine 
(0.5 g/100 g PUA) and goat milk was naturally enriched with PUA (1.19 g/100 g of fat) using 
12% of pomegranate seed pulp added to the feeding of the animals (Franczyk-Żarów et al., 
2014; Modaresi et al., 2011).  
Some other studies have assayed a different approach: the production of enriched 
supplements like nanoparticles and nanoemulsions containing vegetable oils rich in CLNA 
isomers (0.05 g/kg body weight/day in nanoparticles and 2 g in nanoemulsions) (Paul et al., 
2014; Sengupta et al., 2015). These matrices were used to enhance CLNA bioavailability and 
stability and according to the results were efficient in attenuating the effects of 
hypercholesterolemia and diabetes in an animal model.  
The manipulation of ruminants’ diet had led to some interesting results in the 
enhancement of CLA concentrations in milk and ruminants’ meat and it has also been assayed 
for CLNA. The studies focused on the addition of extruded seeds or oils rich in LNA to 
animal diet but, in general, the results obtained were very limited (Ebrahimi et al., 2014; 







1.4. Microbiological production of CLNA: From rumen to cultures 
 
Ruminant products, such as meat, milk and other dairy foods, represent the main source of 
CLA for humans. CLA isomers are formed during LA (C18:2 c9,c12) and -LNA (C18:3 
c9,c12,c15) biohydrogenation process that occurs in rumen, a multi-step pathway carried out 
by different microorganisms on unsaturated fatty acids (Figure 1.1). Once in the rumen, LA 
and -LNA from diet are hydrolyzed through microbial lipases from Butyrivibrio fibrisolvens 
(hydrolyses phospholipids) and Anaerovibrio lipolytica (hydrolyses di- and triacylglycerols), 
for further reactions of isomerization and hydrogenation (Buccioni et al., 2012). The 
biohydrogenation of LA involves two main steps: isomerization of LA to C18:2 c9,t11 (CLA) 
and then hydrogenation of the cis double bond of the conjugated diene to yield C18:1 t11 
(trans-vaccenic acid, TVA), that is further hydrogenated to stearic acid (C18:0) while C18:2 
9,11 isomers, C18:2 8,10 and C18:2 t10,c12 isomers are also produced through this pathway 
(Chilliard et al., 2007). LNA biohydrogenation involves similar reactions in rumen, differing 
in the intermediate products, yielding CLA and CLNA: after hydrolysis, this fatty acid is first 
isomerized at cis-12 position producing RLA. Subsequently, this compound is reduced to 
C18:2 t11,c15 and further converted to three different products: C18:1 t11 (TVA); C18:1 c15 
and C18:1 t15. Only TVA is reduced up to stearic acid (C18:0) (Van Nieuwenhove et al., 
2012). Previous works suggested that CLA isomers can be formed from -LNA as well, 
namely, C18:2 c9,c11, C18:2 t8,t10, C18:2 c10,c12 and C18:2 11,13 (Jouany et al., 2007; Lee 
and Jenkins, 2011; Loor et al., 2005). All intermediates of biohydrogenation are absorbed in 
the gut and transported through the blood stream to different body tissues, thus CLA and 
CLNA can appear in milk and meat fat (Gorissen et al., 2015). CLA is also produced at the 
mammary gland of lactating cows, through the conversion of TVA coming from rumen by the 
9-desaturase. This pathway represents the primary source of CLA in milk (64%) (Griinari et 
al., 2000). On the other hand, CLNA does not have another synthesis pathway yet evidenced, 
so all ruminant milk content apparently comes exclusively from -LNA biohydrogenation 
and ruminants diet. 
The main ruminal bacterium that is involved in the biohydrogenation process is 
Butyrivibrio fibrisolvens, where the linoleate isomerase (LAI) bound to the bacterial 
membrane is responsible for its transformation (Bauman et al., 1999). However, it has been 
reported that ruminal bacteria are not the only ones capable of producing CLA. Species 




of lactobacilli, bifidobacteria and propionibacteria. Therefore, it has been proposed that other 
microorganisms can produce CLNA including those able to produce CLA. This hypothesis 
has been confirmed in some studies using strains of lactobacilli, propionibacteria and 
bifidobacteria (Annexes I and II). 
 
 
Figure 1.1 Scheme of LA and LNA biohydrogenation. Bold arrows indicate the principal 
pathways and simple arrows indicate secondary pathways (Buccioni et al., 2012; Chilliard et 
al., 2007; Gorissen et al., 2015; Jouany et al., 2007; Lee and Jenkins, 2011; Loor et al., 2005; 
Van Nieuwenhove et al., 2007). 
 
1.4.1. CLNA production by lactobacilli 
 
Lactobacillus plantarum AKU 1009a was able to produce CLNA isomers in Man-Rogosa-




(37 ºC, 72 h, 63.00 mg/mL of pure LNA and anaerobic conditions) CLNA was formed at a 
conversion rate of 40.0% under two isomer forms: RLA and C18:3 t9,t11,c15 which 
corresponded to 67.0% and 33.0% of total CLNA, respectively. In a further study by these 
authors (Kishino et al., 2009) the same strain (MRS, 37 ºC, 72 h, 4.00 mg/mL of pure 
substrate and anaerobic conditions) evidenced a 47.0% conversion rate of -LNA after 48 h, 
yielding RLA and C18:3 t9,t11,c15 corresponding to 17.0% and 83.0% of total CLNA, 
respectively. This study also revealed the formation of conjugated isomers of -LNA (C18:3 
c6,c9,c12) at a 46.0% rate after 24 h. Those isomers were C18:3 c6,c9,t11 (19.0% of total 
CLNA) and C18:3 c6,t9,t11 (81.0% of total CLNA). 
Besides L. plantarum, other lactobacilli strains have also been tested (Gorissen et al., 
2011): L. curvatus LMG 13553, L. plantarum ATCC 8014, L. plantarum, IMDO 130201, L. 
plantarum LMG 6907, L. plantarum LMG 13556, L. plantarum LMG 17682, L. sakei 23K, L. 
sakei CG1, L. sakei CTC 494 and L. sakei LMG 13558. These strains assayed with 0.50 
mg/mL of pure LA or -LNA for 72 h at 37 ºC (except for L. sakei and L. curvatus strains 
that were cultured at 30 ºC), converted -LNA to different CLNA isomers (RLA and C18:3 
t9,t11t,c15). Authors concluded that -LNA conversion was strain dependent, since there 
were significant statistical differences. On the other hand, LA was converted by only three of 
these ten strains, pointing out to higher efficiency in converting -LNA than LA. The highest 
CLNA conversion percentage was observed for L. sakei LMG 13558 (60.1%). Using this 
particular bacterial strain in a bioreactor with MRS medium and 0.50 mg/mL of pure LA or 
-LNA for 48 h, the authors tested the effects of temperature (20, 25, 30 and 37 ºC) and pH 
(5.5 and 6.2) during fermentation. Temperature and pH influenced LA and -LNA 
conversion, as well as bacterial growth. These authors also reported the presence of linoleate 
isomerase genes in the genome of strains able to produce CLA and CLNA. 
 
1.4.2. CLNA production by propionibacteria 
 
To the best of our knowledge, Verhulst et al. (1987) were the first to evidence CLNA 
production using Propionibacterium strains. The strains were cultured under anaerobic 
conditions for 48 h at 37 ºC in Brain Heart Infusion (BHI) medium with 0.02 mg/mL of 
different pure substrates, including -LNA and -LNA (C18:3 c6,c9,c12), in order to test their 
capability in isomerizing polyunsaturated long chain fatty acids. Propionibacterium 




shermanii NCIB 10585, NCIB 5964 and NCIB 8099, P. acidipropionici NCIB 8070 and 
NCIB 5958 and P. tecbnicum NCIB 5965 converted, on total, over 30.0% of the -LNA to 
RLA. Propionibacterium acnes was not able to convert -LNA, but did form C18:3 
c6,t10,c12 (50.0%) from -LNA. 
In a recent study (Hennessy et al., 2012) dairy starter propionibacteria were cultured 
under anaerobic condition at 30 ºC for 72 h in cys-MRS medium with 0.45 mg/mL of pure 
LA, -LNA, -LNA or stearidonic acid (C18:4 c6,c9,c12,c15), for evaluation of further 
conversion into the conjugated forms. For -LNA, P. freudenreichii subsp. shermanii 9093 
showed the highest conversion rate, producing two different isomers: RLA (50.3%) and 
C18:3 t9,t11,c15 (3.2%). In comparison with the abovementioned study, this strain showed 
higher conversion capacity than the other eight propionibacteria. Nevertheless it may be noted 
that P. freudenreichii subsp. shermanii 9093 was cultured during a longer period of time, at 
lower temperatures and in a different medium. This strain was also grown in the presence of a 
twenty-fold higher -LNA concentration (0.45 mg/mL vs. 0.02 mg/mL). 
Despite the good production of CLNA by propionibacteria strains, this group is the less 
studied among the CLNA-producing bacteria. Thus, more studies are needed to support the -
LNA isomerizing ability of these microorganisms. 
 
1.4.3. CLNA production by bifidobacteria 
 
According to the current literature, this genus is the most promising and has attracted 
many of the investigations. Coakley et al. (2009), investigated -LNA isomerization ability of 
6 CLA-producing bifidobacteria, derived from human intestinal sources: Bifidobacterium 
lactis Bb12 and Bifidobacterium breve NCIMB 702258, NCTC 11815, NCIMB 8815, 
NCIMB 8807 and DPC 6035. The strains were grown in cys-MRS medium containing 0.24 
and 0.41 mg/mL of pure -LNA at 37 ºC for 42 h under anaerobic conditions. The B. breve 
strains were capable of converting -LNA to RLA and C18:3 t9,t11,c15 at conversion rates 
between 67.6% and 80.7% (assaying 0.24 mg/mL) and 49.4% and 79.1% (with 0.41 mg/mL). 
Recently, Bifidobacterium breve strains, isolated from human breast milk, isomerized 
between 94.0 and 97.0% of 500 µg/mL -LNA to RLA in milk-based medium (24 h at 37 ºC) 
under anaerobic conditions (Villar-Tajadura et al., 2014). 
According to Jiang et al. (1998), the conversion of LA to CLA may be a detoxification 




B. bifidum, B. pseudolongum subsp. pseudolongum and B. breve strains, cultured at 37 ºC for 
72 h in cys-MRS medium with 0.50 mg/mL of -LNA under anaerobic conditions, showed a 
higher conversion rate of -LNA (55.6%-78.4%) than LA (19.5%-53.5%) and strains’ growth 
was inhibited in the presence of -LNA (Gorissen et al., 2010).  
 Gorissen et al. (2012b) conducted a research work with the aim of producing a fermented 
milk with enhanced CLA and CLNA concentrations. Three bacterial strains, namely B. 
bifidum, B. breve and B. pseudolongum subsp. pseudolongum, were each inoculated in milk 
containing sunflower and rapeseed oils (originating milk with 0.50 mg/mL of LA and 0.75 
mg/mL of α-LNA) and incubated at 37 ºC for 24 h under anaerobic conditions, with or 
without co-inoculation of a commercial yoghurt starter culture (Lactobacillus delbrueckii 
subsp. bulgaricus Danisco LYO120 and Streptococcus thermophilus YC180). The starter 
culture was added to increase the amount of free LA and -LNA due to their lipolytic 
activity. The results demonstrated that the growth of bifidobacteria strains was not inhibited 
when the starter culture was added, however, no significant differences were found for 
rumenic acid content in comparison to control (0.08 mg/g fermented milk) and CLNA was 
not even detected with or without starter culture added. The results suggest that the amount of 
free LA and -LNA was too low to initiate isomerization, possibly because of lack of 
lipolytic activity.  
Furthermore, human-derived bifidobacteria strains previously described as CLA and 
CLNA producers, B. breve DPC 6330 and B. breve NCIMB 702258 (Hennessy et al., 2012), 
have been incorporated in a mice diet to evaluate the in vivo production of conjugated fatty 
acids and their effect on lipid metabolism (Barrett et al., 2012; Wall et al., 2009). A 
significant modification of the lipid profiles in liver, adipose tissue, brain, serum and 
intestines was observed, being palmitoleic acid (C16:1 c9), eicosapentaenoic acid (C20:5 ω3) 
and docosahexaenoic acid (C22:6 ω6) the principal FAs altered. CLA levels were also 
significantly higher in comparison to the control samples. However, CLA could have been 
metabolized from CLNA, since this has been observed in vivo (Tsuzuki et al., 2006). These 
results are very promising but further research must be accomplished since mechanisms 
behind lipid profile modification are still unknown.  
In comparison to other groups of microorganisms, bifidobacteria appear to be the best 






1.5. Linoleate isomerase as a screening tool  
 
Commercial high CLA oils are currently produced mainly through alkaline isomerization 
of LA. However this strategy has not been utilized for the elaboration of high CLNA oils to 
bring more easily available sources. Furthemore, chemical catalysts are not isomer selective, 
resulting in a mixture of different positional isomers that cannot be selected (Reaney et al., 
1999). An alternative to this process is the bioconversion of LA and -LNA into pure CLA 
and CLNA single isomers using specific enzymes. As previously mentioned, specific 
microorganisms are capable of producing CLA and CLNA as an intermediate in the 
biological process of biohydrogenation. Isomerization represents the initial step of this 
pathway, occurring in FA containing a c9,c12 double bond structure. Linoleate isomerase 
(LAI) (EC 5.2.1.5) is the enzyme responsible for the conversion of LA and -LNA into their 
conjugated forms, by forming conjugated double bonds from the c9,c12 double bond system 
(Bauman et al., 1999). The presence of a double bond at the c15 position in -LNA has little 
or no effect on the system and therefore biohydrogenation of LNA follows the same pathway 
as that of LA in rumen microorganisms (Kepler and Tove, 1967). 
LAI from the rumen bacterium B. fibrisolvens was first described in 1967 by Kepler and 
Tove (1967). Thereafter, LAI enzymes from Clostridium sporogenes (Peng et al., 2007) and 
Propionibacterium acnes (Liavonchanka et al., 2006) have been characterized. Several 
attempts to solubilize the B. fibrinogens LAI were ineffective, suggesting an association of 
this enzyme to the cell membrane (Kepler and Tove, 1967). Similarly, the C. sporogenes LAI 
is membrane associated and both isomerases are only active on substrates containing c9,c12 
double bonds in C18 fatty acids (Peng et al., 2007). However, C. sporogenes LAI shows 
higher Vmax and Km with LNA than with LA, suggesting that the extra double bond increases 
the reaction rate while decreasing its affinity for the substrate. On the other hand, although the 
P. acnes LAI has similar substrate specificity to that of the B. fibrisolvens and C. sporogenes, 
it is an intracellular soluble cytoplasmic protein capable of converting LA to CLA t10,c12 
single isomer (Rosberg-Cody et al., 2007). Due to its high solubility and high catalytic 
activity, P. acnes LAI is a promising candidate for the biosynthesis of conjugated fatty acids 
(He et al., 2015).  
To the present date, different LAI protein sequences have been annotated in GenBank 
including sequences of the strains P. acnes, L. acidophilus, L. plantarum, L. reuteri, 




delbrueckii subsp. bulgaricus, P. freudenreichii subsp. shermanii, B. fibrisolvens and C. 
sporogenes. According to the amino acid identity percentage of the annotated sequences, 
LAIs can be divided into four groups: 1) LAI from P. acnes that did not show any identity to 
other LAIs; 2) LAI from L. reuteri, L. acidophilus and Lact. lactis spp. lactis; 3) LAIs of L. 
plantarum and R. erythropolis and 4) LAIs of B. dentium and B. breve (Farmani et al., 2010). 
The P. acnes isomerase shares no significant sequence homology to other enzymes except a 
flavin-binding domain in the N-terminal region (Deng et al., 2007). In addition, with the 
exception of P. acnes, LAIs from the species mentioned have significant homology with 
myosin cross-reactive antigen (MRCA) proteins. MCRA-like LAIs are mostly 9,11-
isomerases and are mainly associated with the cell membrane (Farmani et al., 2010).  
Molecular techniques have been recently used to screen and study the putative LAI of 
different species within the genera Lactobacillus and bifidobacteria (Macouzet et al., 2010; 
Gorissen et al., 2011). Among Lactobacillus strains studied the LAI gene sequence is highly 
identical and the putative LAI gene sequence was only identified in the genome of strains able 
to produce CLA and CLNA isomers. Therefore, genotypic screening appears to be a reliable 
method to detect the presence of CLA and CLNA producing strains.  
In order to increase the CLA and CLNA production levels, the use of recombinant 
technologies has been tested during the last decade. The LAI gene has been successfully 
introduced in other microorganisms using either a novel yeast cell surface display system (He 
et al., 2015) or heterologous technologies (Hornung et al., 2005) in Saccharomyces cerevisiae 
and expression as an intracellular enzyme in Escherichia coli (Rosberg-Cody et al., 2007; 
Luo et al., 2013) and Bacillus spp. (Saengkerdsub, 2013). In addition, LAI gene has been 
introduced in plants such as in tobacco seeds (Hornung et al., 2005) and rice (Kohno-Murase 
et al., 2006). Most of these studies focused on the recombinant production of LAIs from P. 
acnes since it is more difficult to develop a recombinant biocatalyst based on membrane-
bound enzymes and problems regarding their solubility may rise during recombinant 
production. 
 
1.6. Stability of CLNA in enriched products 
 
A bioactive compound must be stable after elaboration and during storage period of the 
product. Otherwise it may result in ingestion of hazardous compounds (e.g peroxides from 




lack of data describing the stability of high CLNA products during storage and after 
elaboration. 
However, interesting information can be obtained from studies focused on CLA. Its 
stability in enriched food matrices has been investigated in terms of influence of elaboration 
(i.e thermal processing) and storage conditions (time and temperature). Thus, CLA content 
was stable in naturally enriched milk after UHT processing (142 ºC; 2 s), since total CLA 
content (4.67 g/100 g of FA) was similar to that in raw milk (4.68 g/100 g of FA) (Jones et 
al., 2005). Furthermore, after elaboration of butter and cheese, CLA contents were 4.34 g/100 
g of fat and 4.80 g/100 g of fat, respectively and not significantly different from that in the 
UHT milk. However, Campbell et al. (2003) observed a significant loss of C18:2 c9,t11 in 
fortified milk (2% CLA) after HTST pasteurization (77.2 ºC; 16 s).  
The first clear insight about the effects of processing were reported after assaying cooking 
and frying of milk fat (200-300 ºC, 15 min) as elaidic acid (C18:1 t9) increased proportionally 
to temperature as a result of isomerization of oleic acid (OA, C18:1 c9) while C18:1 c9,t11 
decreased (Precht et al., 1999). In further experiments it was reported that linoleic acid can be 
oxidized at high temperatures to produce CLA isomers (namely C18:2 c9, t11 and C18:2 t10, 
c12) or isomerize to the trans, trans moieties through a intramolecular sigmatropic 
rearrangement (Destaillats and Angers, 2005) that can also affect CLA isomers (Destaillats et 
al., 2005). According to these findings it could be hypothesized that these effects occur only 
with high temperature processing. However, it was demonstrated that trans fatty acids and 
CLA isomers in milk increased as a result of pasteurization and sterilization processes in 
agreement with the abovementioned reactions (Herzallah et al., 2005; Rodríguez-Alcalá et al., 
2014).  
It is known that the deodorization of linseed oil led, as expected, to the formation of trans, 
trans isomers (Wolff, 1993) while oxidation conditions during derivatization of pomegranate 
oil transformed PUA into trans, trans, trans compounds (Chen et al., 2007). Moreover, the 
stability of CLNA to oxidation was compared to that of CLA, LA and -LNA and it was quite 
lower than in these latter fatty acids (Yang et al., 2009). 
Finally, other investigations focused on the study of the stability of CLA during storage. It 
was found elsewhere that throughout 14 d at 4C in the dark or with light exposure, the fatty 
acid concentration including CLA (18:2 c9,t11) did not change in naturally enriched 
pasteurized milk (Lynch et al., 2005) while CLA butter aged (8 wk, 6 ºC) in a similar way to 
regular samples (Mallia et al., 2008). On the other hand, skimmed-milk added with high CLA 




t13, C18:2 c9, c11 and C18:2 c10, c12 as result of microbiological growth  after 3 and 10 wk 
of refrigerated storage (Campbell et al., 2003; Rodríguez-Alcalá and Fontecha, 2007). Recent 
results seem to confirm these findings as in yoghurts elaborated with cow´s milk, the 
concentration of C18:1 c9, t11 decreased after 14 d (5 ºC) (Serafeimidou et al., 2013) while in 
Feta cheese it decreased during aging (Laskaridis et al., 2013).  
Furthermore, studies concerning CLA stability in enriched products after temperature 
treatments have shown that this FA is affected by temperature, originating changes in both 
total content and isomers distribution. Due to the recent interest in CLNA as well as the lack 
of rich edible and commercial sources, little is known about the thermal and storage stability 
of these compounds. These issues must be considered in future research works; available data 
suggests that temperature will increase trans moieties while during storage, if microbiological 
growth takes place, some CLNA isomers may decrease. However, chemical differences with 
CLA as well as presence of other compounds in the assayed high CLNA sources (e.g. 




Due to the potential CLNA bioactivity and the possibility to become a new functional 
ingredient, the main aim of this work was to identify CLNA-producing strains, since some 
groups of dairy bacteria have demonstrated the ability to produce those isomers. In order to 
achieve such identification the following specific objectives were pursued: (i) molecular 
detection of linoleate isomerase gene in Lactobacillus strains, (ii) selection of the strains 
capable of converting LA into CLA isomers in optimized growth conditions, since CLA-
producing strains have been demonstrated to also isomerize LNA into CLNA isomers and (iii) 






2. Material and Methods 
 
2.1. Analytical reagents 
 
Hexane, methanol and dimethylformamide were HPLC grade (VWR Chemicals, West 
Chester, PA), GLC-Nestlé36, methyl undecanoate (99.9%), heptadecnoic acid (99.9%) and 
tritridecanoin (99.9%) were obtained from Nu-Chek Prep, inc. (Elysian, Minnesota, USA) 
while butterfat CRM-164 (EU Commission; Brussels, Belgium) was from Fedelco Inc. 
(Madrid, Spain), sulphuric acid was from Panreac AppliChem (Darmstadt, Germany) and 
Supelco 37 FAME, sodium hydroxide, linolenic acid (LA; C18:2 c9,c12), -linolenic acid (-
LNA; C18:3 c9,c12,c15) and -linolenic acid (-LNA; C18:3 c6,c9,c12) were from Sigma-
Aldrich (St. Louis, MO, USA). Stock solutions of LA and -LNA were prepared at 15 
mg/mL and at 10 mg/mL for -LNA with 2% (w/v) Tween 80 (Sigma) and filter-sterilized 
through a 0.45 µm-pore size membrane (Millipore, Carrigtwohill, Ireland). 
 
2.2. Bacterial strains 
 
A pool of 15 strains was used in this study, including 12 strains of Lactobacillus and 3 
strains of Bifidobacterium (Table 2.1). All strains had been stored at -80 ºC in glycerol (Fisher 
Chemical, Loughborough, UK), a cryoprotectant, at 30% (w/w). They were activated at 2% 
(v/v) in MRS broth (10 mL) (Biokar Diagnostics, Beauvais, France) at 37 ºC overnight. About 
1 mL of each culture was then transferred to 9 mL of new medium containing 0.1% (w/v) of 
Tween 80 (pre-inoculation) and incubated at 37 ºC for 16 h. Two percent (v/v) of these 
cultures were inoculated in fresh MRS broth (10 mL) for the following experiments. For the 
Bifidobacterium strains the culture media were supplemented with 0.05% (w/v) L-cysteine-
HCl (Sigma) and these strains were grown under anaerobic conditions in an anaerobic 
workstation (Whitley DG 250; Don Withley Scientific, Yorkshire, UK.) that was continuously 
sparged with a mixture of 80% nitrogen, 10% hydrogen and 10% carbon dioxide. The 








Table 2.1 Bacterial strains used in this study and corresponding sources. 
Strain Source 
Bifidobacterium animalis subsp. lactis Bb12

 Christian Hansen (HØrsholm, Denmark) 
Bifidobacterium breve NCIMB 702258 NCIMB (Aberdeen, Scotland) 
Bifidobacterium lactis LAFTI

 B94 DSM (Moorebank, NSW, Australia) 
Lactobacillus acidophilus Ki CSK (Ede, Netherlands) 
Lactobacillus acidophilus LAFTI

 L10 DSM (Moorebank, NSW, Australia) 
Lactobacillus acidophilus LA-5

 Christian Hansen (HØrsholm, Denmark) 
Lactobacillus brevis D24 Persimmon isolate (ESB-UCP, Portugal) 
Lactobacillus casei 01 Christian Hansen (HØrsholm, Denmark) 
Lactobacillus casei 431

 Chrristian Hansen (HØrsholm, Denmark) 
Lactobacillus delbruecki subsp. bulgaricus 20081 DSMZ (Braunschweig, Germany) 
Lactobacillus paracasei LAFTI

 L26 DSM (Moorebank, NSW, Australia) 
Lactobacillus plantarum 299v PROBI AB (Lund, Sweden) 
Lactobacillus plantarum D36 Persimmon isolate (ESB-UCP, Portugal) 
Lactobacillus rhamnosus 20021 DSMZ (Braunschweig, Germany) 
Lactobacillus rhamnosus R11 Lallemand (Montréal, QC, Canada) 
 
2.3. Optimization of bacterial growth conditions 
 
Lactobacillus plantarum 299v and Bifidobacterium animalis subsp. lactis Bb12 were 
selected to optimize the growth conditions of Lactobacillus and Bifidobacterium strains, 
respectively. These strains were first activated and pre-inoculated according to the growth 
conditions mentioned previously (section 2.2), where B. animalis subsp. lactis Bb12 was 
always incubated under anaerobic conditions and, in order to compare the influence of the 
atmosphere on Lactobacillus growth, L. plantarum 299v was incubated under aerobic and 
anaerobic conditions throughout the whole experiment. About 2% (v/v) of the activated 
cultures were transferred to new MRS medium (10 mL) in the absence and presence of 0.5 
mg/mL of LA and incubated at 37 ºC during 24 and 48 h for L. plantarum 299v and during 
24, 48 and 72 h for B. animalis subsp. lactis Bb12. All experiments were carried out in 
duplicate. Viable cell numbers were obtained via sequential decimal dilutions in peptone 
water 0.1% (w/v) (Sigma) and plating on MRS agar (Biokar Diagnostics, Beauvais, France) 




at 37 ºC for 24 h at the respective atmosphere conditions and viable cell counts were 
expressed as log (Colony Forming Units (CFU)/mL). Upon incubation, each culture was 
centrifuged at 3 500 rpm, 18 ºC, 5:30 min and the supernatant was collected to be analyzed 
for CLA quantification. 
 
2.4. Molecular detection of linoleate isomerase gene in Lactobacillus strains 
 
A molecular screening of the LAI gene was performed in all Lactobacillus strains (Table 
2.1), in order to determine which strains carried the potential as CLA-producers. 
Bifidobacterium strains were not included, since no specific LAI gene primers have been 
described for these bacteria so far. The strains were first activated at 2% (v/v) in MRS broth 
(10 mL) at 37 ºC overnight and then 1 mL of each culture was transferred to fresh medium (9 
mL) and incubated at 37 ºC for 24 h. The bacterial growth was performed under aerobic 
conditions. After recovery, each culture was centrifuged at 7 000 rpm for 15 min at room 
temperature and the pellet was used for the DNA extraction. Bacterial DNA was extracted 
using the FastDNA
®
 Spin Kit (QBIOgene, Carlsbad, CA, USA) according to the 
manufacturer’s instructions. DNA of each sample was then quantified and the purity 
measured using a nanophotometer (Implen, Isaza, Portugal).  DNA concentrations were 
standardized to 1 ng/µL.  
Real time polymerase chain reaction (qPCR) technique was used to detect the presence of 
the LAI gene in all 12 mentioned strains in a CFX96 Touch Deep Well real-time PCR 
detection system (Biorad). qPCR amplification reactions were optimized using the forward 
primer 5’-CGGACNTACGTYGAYTTAATGG and the reverse primer 5’-
TGGTGMACMACRATCGACAT, according to Gorissen et al. (2011). The amplifications 
were performed in a total volume of 20 µL containing 10 µL of iTaq Universal SYBR Green 
Supermix (Biorad), 0.5 µL of forward primer, 0.5 µL of reverse primer, 4 µL of H2O and 5 
µL of DNA template. Before amplification, the reaction mixtures were incubated at 95 ºC for 
3 min. The PCR conditions were 40 cycles of amplification consisting of denaturation at 95 
ºC for 10 s, annealing at 56 ºC for 25 s and extension at 72 ºC for 25 s. The specificity of all 
the reactions was confirmed through analysis of the melting profile, obtained by dissociation 







2.5. CLA production with selected strains 
 
Lactobacillus brevis D24 and Lactobacillus plantarum D36 were selected to test their 
ability in producing CLA. In order to also include Bifidobacterium strains, Bifidobacterium 
lactis B94 and Bifidobacterium breve NCIMB 702258 were also chosen for this experiment. 
The strains were first activated and pre-inoculated according to the procedures mentioned 
previously (section 2.2) and then inoculated at 2% (v/v) in new MRS broth (10 mL) 
containing 0.5 mg/mL of LA. All inocula were incubated at 37 ºC for 24 and 48 h. The culture 
medium for Bifidobacterium strains was supplemented with 0.05% (w/v) L-cysteine-HCl and 
they were grown under anaerobic conditions. Lactobacillus strains were incubated under 
aerobic conditions throughout the whole experiment.  
In order to optimize CLA production, two additional strategies were undertaken using B. 
breve NCIMB 702258, B. lactis B94 and L. brevis D24. L. plantarum 299v and B. animalis 
subsp. lactis Bb12 were also included in this experiment since their behavior in the presence 
of linoleic acid was well-known from the previous optimization of bacterial growth conditions 
(section 2.3). In the first strategy, it was hypothesized that an early adaptation to precursor 
substrate could enhance metabolic conversion, hence an amount of 0.05 mg/mL of LA was 
also added during pre-inocula preparation. In the second strategy, it was hypothesized that 
early exposure to the precursor LA could inhibit bacterial growth hence no LA was added to 
the pre-icocula, instead, 0.5 mg/mL of LA was added to the culture medium after 7 h of 
incubation of the inocula. Bacterial cultures without substrate were also grown under the 
conditions of both strategies. 
All experiments were carried out in duplicate. Bacterial growth was analyzed through 
plating of sequential decimal dilutions followed by log (CFU/mL) calculation. The samples 
collected were centrifuged at 3 500 rpm, 18 ºC for 5:30 min and both the supernatant and the 
pellet were used for CLA quantification. 
 
2.6. CLA and CLNA production with Bifidobacterium breve NCIMB 702258 
 
Bifidobacterium breve NCIMB 702258 was selected to study its CLNA-producing 
capacity. This strain was first activated and pre-inoculated according to the growth conditions 
mentioned previously (section 2.2). Then it was inoculated at 2% (v/v) in new cys-MRS broth 




and -LNA, where, in this combination, the substrates were added separately at a final 
concentration of 0.5 mg/mL each. The inoculated media were incubated at 37 ºC for 24 h 
under anaerobic conditions. All experiments were carried out in duplicate. Bacterial growth 
was analyzed through plating of sequential decimal dilutions followed by viable cell numbers 
determination. The samples collected were centrifuged at 3 500 rpm, 18 ºC for 5:30 min and 
both the supernatant and the pellet were used for CLA and CLNA quantification. 
 
2.7. CLA and CLNA production in milk with Bifidobacterium breve NCIMB 702258 
 
Bifidobacterium breve NCIMB 702258 was chosen to analyze CLA and CLNA microbial 
production in a food matrix, more precisely, a commercial 1.6% reduced-fat milk. After B. 
breve NCIMB 702258 activation and pre-inoculation in cys-MRS medium, this strain was 
inoculated at 2% (v/v) in milk (10 mL) containing 0.05% (w/v) of L-cysteine-HCl and no 
precursor substrate or 0.5 mg/mL of LA, or -LNA, or both, added separately at a final 
concentration of 0.5 mg/mL each. The inoculated milks were incubated at 37 ºC for 24 h 
under anaerobic conditions. All experiments were carried out in duplicate. Bacterial growth 
was analyzed through plating of sequential decimal dilutions followed by viable cell numbers 
calculation. The samples collected were used for CLA and CLNA quantification. 
 
2.8. Fatty acids analysis 
 
For the analysis of the total fatty acid (FA) composition, growth medium (500 µL), pellets 
or milk samples (500 mg) were prepared according to Castro-Gómez et al. (2014). For 
quantification purposes samples were added with 50 µL of tritridecanoin (1.4 mg/mL in 
hexane) and heptadecanoic acid (1.4 mg/mL in hexane) prior to derivatization and extracts 
were added with 100 µL of methyl undecanoate (1.4 mg/mL in hexane). Fatty acid methyl 
esters (FAME) were analysed in a gas chromatrograph HP6890A (Hewlett-Packard, 
Avondale, PA, USA), equipped with a flame-ionization detector (GLC-FID) and a BPX70 
capillary column (50m x 0.32 mm x 0.25 µm; SGE Europe Ltd, Courtaboeuf, France). 
Analysis conditions were as follows: injector (split 10:1; injection volume 1 µL) and detector 
temperatures were 250 ºC and 270 ºC, respectively; carrier gas was Hydrogen (11 psi) and the 
oven temperature program started at 60 ºC (held 2 min), was raised at 10 ºC/min to 135 ºC 
(held 2 min), then at 10 ºC/min to 165 ºC (held 2 min) and finally at 10 ºC/min to 230 ºC (held 




was assayed for calculation of response factors and detection and quantification limits (LOD: 
0.079 µg FA/mL; LOQ: 0.264 µg FA/ mL). 
 
2.9. Statistical analysis 
 
Results are reported as mean values with their standard deviation. Data were analyzed 
using t-Student test when comparing two groups (p<0.05) and one-way ANOVA for three or 
more groups. In this latter case, Levene's test was applied to verify the homogeneity of the 
variances. Tamhane's T2 (equal variances not assumed) or Bonferroni (equal variances 
assumed) post hoc tests were used to determine differences within groups (p<0.05). Analyses 





3. Results and Discussion 
 
3.1. Optimization of bacterial growth conditions 
 
To guarantee that the strains used in this work would grow well, Lactobacillus plantarum 
299v and Bifidobacterium animalis subsp. lactis Bb12 were selected to optimize the growth 
conditions of Lactobacillus and Bifidobacterium strains, respectively. Since these strains were 
the first available in stock, at the time, they were selected for this experiment. The parameters 
analyzed were the incubation time (0, 24 and 48 h) and the atmosphere conditions (aerobic 
and anaerobic) in the presence and absence of LA. 
 
 
Figure 3.1 Bacterial growth of L. plantarum 299v at 0, 24 and 48 h of incubation in the 
absence () and presence () of LA (0.5 mg/mL) under aerobic (a) and anaerobic (b) 
conditions. Results are expressed in log (CFU/mL). 
 
Concerning L. plantarum 299v (Figure 3.1a, b), no significant differences (p>0.05) were 
observed between 0, 24 and 48 h of incubation at both atmospheres, although this strain 
growth tended to be higher after 24 h under anaerobic conditions (8.48 and 9.38 log 
(CFU/mL) with and without LA, respectively) (Figure 3.1b). Smetanková et al. (2012) 
observed that after incubating L. plantarum 115 and L. plantarum 2L2 in MRS broth at 37 ºC 
for 48h under aerobic and anaerobic conditions, these strains have grown faster under 
anaerobic conditions. Similar results were obtained by Fu and Mathews (1999) that incubated 
L. plantarum ATCC 21028 in a synthetic lactose medium at 37 ºC and saw a faster growth 





hour of fermentation. On the other hand, Murphy and Condon (1984) in their study with L. 





anaerobic conditions when this strain was incubated at 30 ºC in MRS medium supplemented 
with glucose, although the anaerobic cultures departed from exponential growth at a higher 
cell density. 
Some studies (Dilika et al., 2000; Zheng et al., 2005) reported that LA has anti-bacterial 
activity, however, the growth inhibition observed in this experiment was minimum. Li et al. 
(2011) did not detect a significant alteration in cell counts of L. acidophilus F0221 when 
treated with LA at concentrations lower than 1 mg/mL, but in the presence of 0.040 mg/mL of 
LA L. casei Shirota and L. bulgaricus growth was significantly reduced in Kankaanpää et al. 
(2001) study. At an even lower LA concentration (0.025 mg/mL), bacterial growth of L. 
acidophilus ATCC 4356, L. bulgaricus and L. fermentum was reduced in 20% to 50% and L. 
reuteri ATCC 23272 was inhibited between 50-70%, while the growth of two L. casei strains 
and L. helveticus ATCC 15009 was not significantly affected (Jiang et al., 1998). 
Lactobacillus behavior in the presence of LA seems to be a strain-specific trait, since at 0.5 
mg/mL of LA the number of viable cells of L. plantarum 299v was not greatly affected, while 
at lower concentrations other lactobacilli strains have been significantly inhibited. 
 
 
Figure 3.2 Bacterial growth of B. animalis subsp. lactis Bb12 at 0, 24, 48 and 72 h of 
incubation in the absence () and presence () of LA (0.5 mg/mL) under anaerobic 
conditions. Results are expressed in log (CFU/mL). 
 
Bifidobacterium strains are strict anaerobes (Bernhard and Field, 2000) so B. animalis 
subsp. lactis Bb12 was only tested under anaerobic conditions. Viable cell numbers were 
determined throughout a 72 h period since some studies with Bifidobacterium strains have 
incubated these bacteria for that long (Gorissen et al., 2012a; Hennessy et al., 2012; Rosberg-
Cody et al., 2004). No differences (p>0.05) were detected between 0, 24, 48 and 72 h of 




higher after 24 h in media containing no LA. Similarly to L. plantarum 299v, the reduction of 
viable cell numbers of B. animalis subsp. lactis Bb12 was not considerable in the presence of 
LA. Van Nieuwenhove et al. (2007) did not detect growth inhibition of B. bifidum CRL 1399 
with addition of up to 0.1 mg/mL of LA to the culture medium, so did not Oh et al. (2003) 
with a B. breve and a B. pseudocatenulatum strains in the presence of 0.5 mg/mL of LA. In a 
further study, Gorissen et al. (2010) also showed that the growth of five B. animalis subsp. 
lactis strains, including the one used in this experiment, was not inhibited with 0.5 mg/mL of 
LA in the culture medium, whereas cell numbers of B. angulatum LMG 11568, B. longum 
subsp. infantis LMG 11588, B. pseudocatenulatum LMG 10505 and B. pseudocatenulatum 
LMG 11593 were negatively affected. As for Lactobacillus, Bifidobacterium behavior in the 
presence of LA seems to be a strain-specific trait, since at the same concentration some strains 
were shown to be inhibited but others were not. 
 
Table 3.1 LA reduction (%) and CLA production (µg/mL) by L. plantarum 299v and B. 








L. plantarum 299v 
Aerobic 
24 56.45  15.26 1.96  0.42
b
 
48 65.41   8.98 2.49  0.22ª 
Anaerobic 
24 58.26  14.21 2.57  0.03 
48 69.28   3.27 2.82  0.47 
B. animalis subsp. lactis 
Bb12 
Anaerobic 
24 51.28  2.41
c
 0.11  0.01
b
 
48 60.32  2.10
b
 0.62  0.03ª 





* Average value ± standard deviation. 
a, b, c - Different superscript letters stand for significant differences (p<0.05) between 24 h 
vs. 48 h vs. 72 h. 
ND = not detected. 
 
After the respective incubation time, the supernatant of each culture was collected to be 
analyzed for FA (LA and CLA) quantification. In general, LA reduction was above 50% for 
L. plantarum 299v and B. animalis subsp. lactis Bb12 (Table 3.1). No significant differences 
(p>0.05)  were observed between 24 and 48 h of incubation for L. plantarum 299v at both 
atmosphere conditions, but for B. animalis subsp. lactis Bb12 the percentage of LA reduction 
increased over time, being significantly higher after 72 h of incubation (64.54%). Regarding 




conditions reported a statistically significant (p<0.05) increase in CLA production between 24 
and 48 h having reached 2.49 µg/mL by 48 h. On the other hand, under anaerobic conditions, 
the amount of CLA was not statistically different (p>0.05) between incubation times, yet 
absolute amounts were always higher compared to those obtained under aerobic conditions. 
The isomers detected were C18:2 c9,t11 and C18:2 t10,c12 (data not shown). Kishino et al. 
(2002b) was able to detect higher amounts of CLA with L. plantarum AKU 1138, L. 
plantarum AKU 1009a, L. plantarum JCM 8341 and L. plantarum JCM 1551 when grown at 
37 ºC for 72 h. The values ranged from 190 to 3 410 µg/mL corresponding to C18:2 c9,t11 
and C18:2 t9,t11. These higher levels of CLA could be due to the use of an eight-fold higher 
LA concentration (4 mg/mL). Nevertheless, with a five-fold lower concentration of added LA 
(0.1 mg/mL) than that applied in our research, Liu et al. (2011) observed that ca. 25% of the 
LA was converted to C18:2 c9,t11 and C18:2 t10,c12 by L. plantarum Ip15 grown at 30 ºC 
for 48 h, while in our experiment the concentration of CLA formed by L. plantarum 299v was 
very low in comparison to the percentage of LA reduction.  
In the case of B. animalis subsp. lactis Bb12, CLA production reached maximum 
concentration by 48 h (0.62 µg/mL) and C18:2 c9,t11 and C18:2 t10,c12 were the identified 
isomers (data not shown). At an equal LA concentration to the one used in this study (0.5 
mg/mL) and with the same strain grown at 37 ºC for 72 h, Gorissen et al. (2010) were not able 
to observe any CLA production, whereas at a higher concentration (1 mg/mL) and with the 
same strain, Rodríguez-Alcalá et al. (2011) were able to detect the production of 7.12 µg/mL 
of CLA isomers, mostly C18:2 c9,t11 and C18:2 t10,c12. Therefore, the concentration of LA 
in the culture medium seems to affect the amount of CLA formed by B. animalis subsp. lactis 
Bb12, even though it is not a substantial production. Moreover, similarly to the results 
reported for L. plantarum 299v, the low concentrations of CLA produced are not duly 
correlated with the considerably high LA reduction percentages (over 50%). A possible 
hypothesis for this scenario could be the degradation of LA, although that could have exposed 
the strain to an oxidative environment and toxic compounds causing a considerable growth 
inhibition, which was not observed in this work in the presence of LA. Other possible 
hypotheses are that the strains could be using the substrate in a different way than the 
expected, for example the incorporation of LA into their cells’ membrane (Jenkins and 
Courtney, 2003; Rosberg-Cody et al., 2007) or the conversion of LA to hydroxy fatty acids 
(HFAs) (Kim et al., 2003; Kishino et al., 2002b). Therefore, in the following experiments the 





According to the bacterial growth and CLA production results, the following experiments 
with Lactobacillus were set to be performed under aerobic conditions, since the exposure to 
an anaerobic environment did not notoriously improve L. plantarum 299v performance 
(viable cell numbers and CLA concentration values under anaerobic conditions were not 
considerably higher). Regarding the incubation time, although L. plantarum 299v and B. 
animalis ssp lactis Bb12 tended to report higher viable cell numbers at 24 h growth, a higher 
CLA concentration was detected by 48 h incubation for both strains. Based on these 
observations the incubation time in the following experiments with Lactobacillus and 
Bifidobacterium strains was set to 24 and 48 h. 
 
3.2. Molecular detection of linoleate isomerase gene in Lactobacillus strains 
 
In order to identify high functionality potential in Lactobacillus strains to produce CLA 
isomers, a molecular screening of the LAI gene was performed in the 12 Lactobacillus strains. 
The DNA extracted from all strains revealed a purity degree above 1.75 (A260/A280) (data 
not shown). The real-time PCR amplification curves and melting curves for the positive 
strains demonstrating the presence of the linoleate isomerase gene are presented in Figures 3.3 
and 3.4, respectively. 
 
 
Figure 3.3 Real-time PCR amplification curves demonstrating the presence of the linoleate 









Figure 3.4 Real-time PCR melting curves of L. brevis D24, L. plantarum D36 and L. 
plantarum 299v at the highest peak and overlapped. 
 
Among all the 12 strains tested, only three revealed the presence of LAI gene according to 
the real-time PCR amplification curves: Lactobacillus brevis D24, Lactobacillus plantarum 
D36 and Lactobacillus plantarum 299v (Figure 3.3). The specificity of the amplification 
product formed can be confirmed through the real-time PCR melting curves (Figure 3.4), 
where the overlap of the corresponding melting curves indicate that the melting temperature 
of the PCR product for all three strains is the same, hence the PCR product must be the same. 
Few studies have been performed for the detection of LAI gene in Lactobacillus strains and 
only Gorissen et al. (2011) were able to also detect the presence of this gene in other strains 
of Lactobacillus plantarum. Macouzet et al. (2010) were able to detect the LAI gene in 
Lactobacillus acidophilus strains, however the primers used were based on a putative gene 
sequence of other Lactobacillus species (i.e. Lactobacillus reuteri LI (EC 5.2.1.5)), whereas 
the primers used by Gorissen et al. (2011), and those used in our study, were constructed 
based on the LAI gene sequence of Lactobacillus sakei 23K. These findings suggest that the 
LAI gene sequence may be different between Lactobacillus species, not existing a single pair 
of specific primers applicable for all Lactobacillus strains. However, more studies should be 
undertaken on this subject in order to validate this hypothesis. 
To the best of our knowledge, no other studies have described the presence of LAI gene in 
Lactobacillus brevis strains, so this is the first study to accomplish such a feat. 
Lactobacillus plantarum D36 and L. brevis D24, as they were positive for the LAI gene 
presence, were chosen for the following set of experiments where it was tested their ability to 
isomerize LA. Lactobacillus plantarum 299v was rejected because although the molecular 
screening had given a positive result, in the optimization of bacterial growth conditions 
experiment (section 3.1) it was observed that the concentration of CLA formed was too low in 




positive and LA is decreased but CLA production remains low, may suggest that LA is being 
absorbed or converted into other products not yet described by the strain. Nevertheless, it 
cannot be overlooked that the fact that the strain is LAI gene-positive does not necessarily 
imply LA conversion into CLA if the enzyme is not expressed by the strain under the growth 
conditions applied. 
 
3.3. CLA production with selected strains 
 
CLNA isomers are chemically similar to CLA isomers and previous studies (Gorissen et 
al., 2010; Hennessy et al., 2012; Villar-Tajadura et al., 2014) have seen that the majority of 
the strains that were able to produce CLA could also form CLNA isomers. Therefore, in order 
to test strains CLNA producing ability, it was first tested their capacity to form CLA isomers. 
According to the results in the molecular detection of the LAI gene in Lactobacillus strains 
(section 3.2), the gene positive strains L. brevis D24 and L. plantarum D36 were selected to 
test their capability in producing CLA isomers. Although no molecular screening could be 
applied for the Bifidobacterium strains, it was important to also include these bacteria in this 
study. B. breve NCIMB 702258 was chosen since B. breve strains have demonstrated CLA-
producing capacity in other studies (Coakley et al., 2009; Gorissen et al., 2010; Hennessy et 
al., 2012)  and B. lactis B94 was included because at the time there were no more 
Bifidobacterium strains available in stock. 
 
  
Figure 3.5 Bacterial growth of B. breve NCIMB 702258, B. lactis B94, L. brevis D24 and L. 
plantarum D36 at 0 (), 24 ( ) and 48 h () of incubation in the presence of LA (0.5 
mg/mL). Results are expressed in log (CFU/mL). 






Concerning bacterial growth (Figure 3.5), with exception to B. breve NCIMB 702258 that 
did not grow after 48 h no significant differences (p>0.05) were observed between 0, 24 and 
48 h of incubation for each strain, although B.lactis B94 viable cell numbers tended to be 
higher after 24 h of incubation. 
 
Table 3.2 LA reduction (%) and CLA formation (µg/mL) by selected strains in the culture 
supernatant collected after 24 and 48 h of incubation.  
Strain Incubation time (h) LA reduction (%)* CLA (µg/mL)* 
B. breve NCIMB 702258 
24 66.13  1.18
b
 155.83  5.00
a
 
48 71.14  1.76ª 139.30  5.28
b
 
B. lactis B94 
24 40.36  1.24
b
 ND 
48 49.98  2.36
a
 ND 
L. brevis D24 
24 57.47  0.54 0.93  0.05ª 
48 58.26  0.44 0.74  0.04
b
 
L. plantarum D36 
24 59.07  0.75
b
 1.18  0.06ª 





* Average value ± standard deviation. 
a, b - Different superscript letters stand for significant differences (p<0.05) between 24 h 
vs. 48h. 
ND = not detected. 
 
Analysis of supernatants collected from each culture (Table 3.2) revealed overall LA 
reduction percentages above 40%. These values were significantly higher (p<0.05) after 48 h 
for all strains, except for L. brevis D24 whose LA reduction percentages were not different 
(p>0.05) between both incubation times. In what concerns CLA production, values were 
significantly higher after 24 h of incubation for all the strains tested, except for B. lactis B94 
for which no CLA production was detected. Bifidobacterium breve NCIMB 702258 showed 
the best CLA-producing ability with values ranging from 139.30 µg/mL at 48 h to 155.83 
µg/mL at 24 h (Table 3.2), being C18:2 c9,t11 the major isomer formed. Its capacity to form 
CLA isomers is proved by the peaks present in the corresponding chromatograms shown in 
Figure 3.6. Indeed, other studies have also demonstrated B. breve strains to be good CLA 
producers. In their study with other B. breve strains (NCFB 2257, NCFB 2258, NCTC 11815, 
NCIMB 8815 and NCIMB 8807) grown at 37 ºC for 48 h with 0.55 mg/mL of LA, Coakley et 
al. (2003) were also able to detect evident amounts of CLA (122.9-364.0 µg/mL), specifically 
C18:2 c9,t11. Other isomers such as C18:2 t10,c12 and C18:2 t9,t11 were also identified but 




ZL12-28, B. breve 29M2 and B. breve M7-70 also showed ability to produce CLA in Villar-
Tajadura et al. (2014) study, having reached values of 170.6, 158.7 and 170.3 µg/mL, 
respectively. The main isomer identified was C18:2 c9,t11, but C18:2 t10,c12 and C18:2 
t9,t11 were also detected. In another research work (Hennessy et al., 2012), that also studied 
B. breve NCIMB 702258, it was observed a production of 259.0 µg/mL of CLA when the 
strain was grown at 37 ºC for 72 h with 0.45 mg/mL of LA. The main isomers identified was 
C18:2 c9,t11, but C18:2 t9,t11 was also present. 
No other studies have tested B. lactis strains ability to produce CLA isomers, although in 
the present study it was observed that with B. lactis B94 no CLA was detected at both 
incubation times, even though LA reduction was considerably high. A similar scenario was 
observed for L. brevis D24 and L. plantarum D36, which although LAI gene-positive could 
not produce significant amounts of CLA, similarly to what had been observed with L. 
plantarum 299v (section 3.1). On the other hand, previous reports (Kishino et al., 2002b; Xu 
et al., 2008) were able to detect CLA production by L. brevis and L. plantarum strains, and 
Kishino et al. (2002b) also found HFAs as intermediate metabolites that we have not been 
able to identify. 
In this research, negative controls (with substrate but no strain) were also incubated 
throughout 24 and 48 h. Fatty acid analysis revealed an LA reduction between 10% and 20% 
in these controls (data not shown), but in the presence of any strain, those values were much 
higher (Table 3.2). Therefore, it was hypothesized that it was the presence of the bacteria that 
caused LA reduction and so we further analyzed the pellets to test whether the substrate was 











Figure 3.6 Chromatogram profile assessed by gas chromatography of the fatty acids present 
in the culture supernatant of B. breve NCIMB 702258 grown with LA (0.5 mg/mL) for 24 (a) 








Table 3.3 Fatty acids composition (µg/mg) of selected strains’ pellets after 24 and 48 h of incubation in the presence of LA (0.5 mg/mL). 
 Strains 
 B. breve NCIMB 702258 B. lactis B94 L. brevis D24 L. plantarum D36 
Fatty acid* 24 h 48 h 24 h 48 h 24 h 48 h 24 h 48 h 
C4 2.29  0.11ª 0.77  0.09
b
 0.44  0.04 0.32  <0.01 0.27  0.01 0.28  0.02 0.26  <0.01 0.27  0.01 
C14 1.25  0.06ª 0.43  0.03
b
 0.25  <0.01 0.21  0.02 0.07  <0.01 0.08  <0.01 0.07  0.01 0.08  <0.01 
C16 6.69  0.33ª 2.28  0.04
b
 1.82  0.02 1.66  0.12 0.65  0.03 0.68  0.08 0.57  0.07
b
 0.69  0.02
a
 
C18 0.55  0.03ª 0.18  0.03
b
 0.16  0.03 0.16  0.01 ND ND 0.05  <0.01 0.06  0.01 
C18:1 c9 7.06  0.35ª 2.47  0.03
b
 1.33  0.05 1.36  <0.01 0.63  0.03 0.73  0.08 0.55  0.07
b
 0.73  0.04
a
 
C18:1 c11 1.38  0.07ª 0.46  0.02
b
 0.10  0.01 0.10  0.01 0.11  <0.01 0.12  0.01 0.10  0.01 0.13  0.01 
C18:2 c9,c12 7.73  0.37ª 2.68  0.05
b
 2.05  0.11 2.13  0.12 3.94  0.14 4.14  0.31 3.59  0.27
b
 3.99  0.13
a
 
C18:2 c9,c15 0.65  0.03ª 0.21  0.02
b
 ND ND ND ND ND ND 
cyc 19:0(c9) 0.65  0.03ª 0.24  0.02
b
 0.81  0.02 0.76  0.04 1.19  0.05 1.20  0.10 1.06  0.11 1.25  0.06 
C18:2 c9,t11 6.16  0.31ª 2.02  0.03
b
 ND ND ND ND ND ND 
C18:2 CLA tt 0.85  0.04ª 0.32  0.05
b
 ND ND ND ND ND ND 
 CLA 7.01  0.35ª 2.34  0.02
b
 ND ND ND ND ND ND 
 FA 35.27  1.76
a
 12.06  0.11
b
 6.97  0.28 6.72  0.29 6.87  0.26 7.23  0.60 6.27  <0.01
b
 7.21  0.29
a
 
* Average value ± standard deviation. 
a, b - Different superscript letters for significant differences (p<0.05) between 24 h vs. 48 h. 
c = cis double bound; t = trans double bound; cyc = cyclopropane fatty acid; ∑ = total; CLA = conjugated linoleic acid; FA = fatty acids;    





The analysis to strains’ pellet (Table 3.3) showed that LA (C18:2 c9,c12) was present in all 
of them, being its concentration significantly higher (p<0.05) after 48 h in L. plantarum D36. 
Amounts of C16 and C18:1 c9 were also significantly higher in L. plantarum D36 after 48 h, 
which led to a significantly higher total amount of FA (7.21 µg/mg). Although not significant 
(p>0.05) and of low order of magnitude, an increment in LA amount was also observed in B. 
lactis B94 and L. brevis D24 after 48 h. This may suggests that the LA added to the medium 
was absorbed by these strains over time. 
Few studies have focused on pellets’ analysis, but Jenkins and Courtney (2003) also 
detected the accumulation of LA in Lactobacillus strains, more precisely at the cell 
membrane, when grown in the presence of this fatty acid. Polyunsaturated fatty acids 
(PUFAs) like LA are toxic to bacteria (Maia et al., 2010; Zheng et al., 2005) and LA 
isomerization consists of a detoxification mechanism (Jiang et al., 1998). Rosberg-Cody et al. 
(2007) claimed that the incorporation of PUFAs, namely at the cell membrane, could be part 
of that mechanism. Therefore, a hypothesis could be that LA is being absorbed into the 
membranes, isomerized and delivered to the medium. However, CLA isomers were only 
detected at considerable amounts for B. breve NCIMB 702258. Nevertheless, further studies 
should be undertaken to assure that the strains tested in this work are actually incorporating 
LA into the cell membrane, since a separation of cell structures was not applied for the lipids 
analysis. The determination of whether the substrate is being absorbed in a free form or not, 
would also be of interest. 
Bifidobacterium lactis B94, L. brevis D24 and L. plantarum D36 have revealed LA 
reduction percentages above 40%, which are equivalent to more than 200 µg/mL of the 
substrate added to the medium. However, the amount of LA detected in these strains’ pellet is 
very low (between 2.05 and 4.14 µg/mL), therefore the LA reduction verified cannot be 
explained only by substrate’s absorption hypothesis. Besides isomerization, saturation 
metabolism of PUFAs may also include conversion into other metabolites such as HFAs or 
oxo fatty acids and partially saturated trans fatty acids (Kishino et al., 2013). So, it is possible 
that LA is being transformed into other unknown compounds instead, such as HFAs. Some 
studies (Kim et al., 2003; Kishino et al., 2002b) have detected the presence of HFAs with 
lactic acid bacteria grown in the presence of LA. Ogawa et al. (2001) referred that HFAs 
could be intermediates of LA conversion to CLA. However, in our work, those compounds 
were not detected. 
Usually CLA quantification is performed analyzing the culture supernatant, however, CLA 




detected in the other strains. However, it is unknown if those isomers were absorbed after LA 
isomerization or if they are naturally present in B. breve NCIMB 702258. Therefore, in order 
to better evaluate LA’s influence on fatty acids composition, an analysis of the strains’ pellet 
grown without any substrate was performed in the following experiments. 
 
3.3.1. Addition of LA to the pre-inocula and inocula 
 
Since no significant amount of CLA was being produced by the expected strains, two 
strategies were undertaken to optimize CLA production using B. breve NCIMB 702258, B. 
lactis B94 and L. brevis D24. Lactobacillus plantarum D36 was excluded because although it 
had a similar CLA production to L. brevis D24 at 24 h, no production was detected after 48 h. 
Lactobacillus plantarum 299v and B. animalis subsp. lactis Bb12 were also included since 
their behavior in the presence of linoleic acid was well-known from the optimization of 
bacterial growth conditions (section 2.3). In the first strategy, beside the inocula, the substrate 
was also added during pre-inocula preparation at a concentration of 0.05 mg/mL. The purpose 
was to provide an adaption time to LA before inoculation, so that its presence would not 





Figure 3.7 Bacterial growth of B. animalis subsp. lactis Bb12 (a), B. breve NCIMB 702258 
(b), B. lactis B94 (c), L. brevis D24 (d) and L. plantarum 299v (e) at 0, 24 and 48 h of 
incubation in the absence () and presence () of LA added to the pre-inocula (0.05 mg/mL) 
and inocula (0.5 mg/mL). Results are expressed in log (CFU/mL). Different letters for 
significant differences (p<0.05) between 0 h vs. 24 h vs. 48 h. 
* No significant growth was detected. 
 
In the absence of LA, B. animalis subsp. lactis Bb12, B. breve NCIMB 702258 and L. 
plantarum 299v revealed significantly higher (p<0.05) viable cell numbers after 24 h of 
incubation (Figure 3.7), yet after 48 h viable cell numbers were significantly lowered. B. 








LA was added to the culture medium, no differences (p>0.05) were observed for all strains 
assayed, although B. lactis B94 viable cell numbers tended to be higher after 24 h. Viable cell 
numbers were slightly lowered in the presence of LA after 24 and 48 h of incubation for all 
strains but B. lactis B94 at 24 h, which revealed similar cell counts. Lactobacillus plantarum 
299v and B. animalis subsp. lactis Bb12 revealed a similar behavior to the one observed in the 
optimization of bacterial growth conditions (section 3.1). For example, in the case of B. 
animalis subsp. lactis Bb12, after 24 h of incubation in the optimization experiment, viable 
cell counts were of 8.43 and 9.42 log (CFU/mL) (with and without LA, respectively). In this 
experimental strategy where LA was also added during pre-inocula preparation, the values 
observed were almost the same, i.e. 8.58 and 9.46 log (CFU/mL) (with and without LA, 
respectively). Thus, the strategy undertaken in this experiment was not truly successful as far 
as bacterial growth is concerned. 
 
Table 3.4 LA reduction (%) and CLA formation (µg/mL) by selected strains grown in the 
presence of LA added to the pre-inocula (0.05 mg/mL) and inocula (0.5 mg/mL) in the culture 
supernatant collected after 24 and 48 h of incubation. 
Strain Incubation time (h) LA reduction (%)* CLA (µg/mL)* 
B. animalis subsp. lactis 
Bb12 
24 45.90  0.97 0.99  0.05ª 
48 55.85  1.98 ND
b
 
B. breve NCIMB 702258 
24 61.25  2.04
b
 145.85  20.65 
48 65.25  1.11
a
 151.10  3.13 
B. lactis B94 
24 41.64  0.42
b
 0.64  0.03ª 
48 57.57  0.05ª 0.40  0.02
b
 
L. brevis D24 
24 59.09  1.38 ND 
48 60.98  1.26 ND 
L. plantarum 299v 
24 31.97  2.86
b
 1.69  0.56ª 
48 42.23  6.28ª 0.65  0.03
b
 
* Average value ± standard deviation. 
a, b - Different superscript letters for significant differences (p<0.05) between 24 h vs. 48h. 
ND = not detected. 
 
The analysis of each culture supernatant (Table 3.4), revealed that the LA was reduced at 
least by 30% by 24 h incubation and that overall values were significantly higher (p<0.05) 
after 48 h of incubation. CLA production capacity, independently of the order of magnitude, 
was either similar between both sampling points (in the case of B. breve NCIMB 702258) or 
significantly higher by 24 h in comparison to the values reported by 48 h. The ability of B. 




the concentration of CLA produced ranged from 145.85 µg/mL at 24 h to 151.10 µg/mL at 48 
h, being C18:2 c9,t11 the major isomer identified (the corresponding peaks may be seen in the 
chromatograms of Figure 3.8). In comparison with the results obtained before in the 
experiments of optimization of bacterial growth conditions (section 3.1) and of CLA 
production by selected strains (section 3.3), LA reduction percentages and CLA production 
were not improved in this experiment. In fact, CLA production levels in L. plantarum 299v 
were lowered and L. brevis D24 did not produce any amount of CLA, while previously some 
production had been detected, even though it was not to a considerable extent. The strategy 
undertaken in this experiment seemed to only work with B. lactis B94, as LA reduction was 
slightly enhanced and the production of CLA isomers was detected, unlike what had been 
observed in section 3.3. 
Providing an adaptation to LA period did not reflect in an improvement of CLA 
production; indeed, with the exception of B. breve NCIMB 702228, a considerable high LA 
















Figure 3.8 Chromatogram profile assessed by gas chromatography of the fatty acids present 
in the culture supernatant of B. breve NCIMB 702258 grown for 24 (a) and 48 h (b) with LA 
added to the pre-inocula (0.05 mg/mL) and inocula (0.5 mg/mL). 
 
The analysis of the fatty acid composition of the B. animalis subsp. lactis Bb12 pellet 
(Table 3.5) revealed that there was an accumulation of LA (C18:2 c9,c12) at both incubation 
times. Simultaneously, C18:1 c11, cyc 19:0(c9) and cyc 19:0(c11) (lactobacillic acid) were 
significantly reduced (p<0.05) in the presence of LA. After 48 h of incubation with substrate, 
a significant increase of C18:1 c9, as well of the CLA isomers, such as C18:2 t10,c12 and 
C18:2 CLA t,t, was observed. The total amount of CLA and FA was significantly higher after 




Table 3.5 Fatty acids composition (µg/mg) of B. animalis subsp. lactis Bb12 pellet after 24 
and 48 h of incubation in the absence (LA-) and presence (LA+) of LA added to the pre-
inocula (0.05 mg/mL) and inocula (0.5 mg/mL). 
 Incubation time 
 24 h 48 h 
Fatty acid* LA- LA+ LA- LA+ 
C4 0.10  0.05 0.15  0.07 0.12  0.03 0.20  0.02 
C14 0.10  0.04 0.07  0.03 0.12  0.03 0.10  0.01 
C16 0.39  0.19 0.31  0.15 0.46  0.12 0.48  0.06 
C18 0.04  0.03 0.05  0.03 0.07  0.02 0.11  0.02 
C18:1 c9 0.74  0.35
b
 1.31  0.61
b
 1.11  0.28
b
 2.41  0.43ª 
C18:1 c11 0.66  0.30ª 0.16  0.07
b
 0.70  0.17ª 0.23  0.04
b
 
C18:2 c9,c12 0.02  0.01
b
 1.59  0.74
a
 0.02  0.01
b
 3.02  0.61
a
 
cyc 19:0(c9) 0.70  0.33
ab
 0.33  0.14
bc
 0.78  0.21ª 0.44  0.04
c
 
cyc 19:0(c11) 0.17  0.08ª 0.02  0.01
b
 0.18  0.05ª 0.02  <0.01
b
 
C18:2 c9,t11 0.01  0.01ª 0.04  0.02ª 0.03  0.01ª 0.08  0.02ª 
C18:2 t10,c12 0.02  0.01
b
 0.04  0.02
b
 0.03  0.01
b
 0.08  0.01ª 
C18:2 CLA cc1 0.01  <0.01 0.01  <0.01 0.01  <0.01 0.01  0.01 
C18:2 CLA cc2 0.01  <0.01 0.01  <0.01 0.02  0.01 0.02  <0.01 
C18:2 CLA t,t 0.02  0.01
b
 0.02  0.01
b
 0.02  <0.01
b
 0.05  0.01ª 
 CLA 0.07  0.03
b
 0.12  0.05
b
 0.10  0.03
b
 0.24  0.06ª 
 FA 3.00  1.39
b
 4.11  1.90
b
 3.66  0.96
b
 7.24  1.29ª 
* Average value ± standard deviation. 
a, b, c - Different superscript letters for significant differences (p<0.05) between absence 
vs. presence of LA. 
c = cis double bound; t = trans double bound; cyc = cyclopropane fatty acid; ∑ = total; 
CLA = conjugated linoleic acid; FA = fatty acids. 
 
In the presence of the substrate, LA (C18:2 c9,c12) and C18:2 c9,c15 were detected in the 
B. breve NCIMB 702258 pellet (Table 3.6), but not when the strain was grown without LA. 
At the same time, after 24 h of incubation in the presence of LA, C4 was significantly 
enhanced (especially after 48 h), while C18 and cyc 19:0(c9) were significantly reduced 
(p<0.05). After 48 h of incubation in the presence of the substrate, there was an accumulation 
of LA (18:2 c9,c12) in the pellet and the level of C16, C18:2 c9,c15 and each CLA isomer 
was significantly higher. In fact, in comparison to the pellet without substrate, the total 
content of CLA and FA in the pellet with substrate was 40-fold (4.19 µg/mg) and 6-fold 





Table 3.6 Fatty acids composition (µg/mg) of B. breve NCIMB 702258 pellet after 24 and 48 
h of incubation in the absence (LA-) and presence (LA+) of LA added to the pre-inocula (0.05 
mg/mL) and inocula (0.5 mg/mL). 
 Incubation time 
 24 h 48 h 
Fatty acid* LA- LA+ LA- LA+ 
C4 0.20  0.15
bc
 0.34  0.08
b
 0.17  0.05
c
 1.07  0.05
a
 
C14 0.38  0.25 0.19  0.03 0.30  0.10 0.70  0.04 
C16 1.78  0.31
b
 1.14  0.22
b
 1.46  0.45
b
 3.57  0.18
a
 
C18 0.26  0.06
a
 0.08  0.06
b
 0.22  0.06
a
 0.28  0.01
a
 
C18:1 c9 1.64  0.21
b
 1.10  0.19
b
 1.30  0.38
b
 4.00  0.20
a
 
C18:1 c11 0.12  0.08
b
 0.08  0.02
b
 0.09  0.03
b









 4.71  0.24ª 
C18:2 c9,c15 ND
c




 0.15  0.01ª 
cyc 19:0(c9) 0.36  0.26ª 0.08  0.01
b
 0.34  0.11ª 0.30  0.02ª 
C18:2 c9,t11 0.03  0.02
c
 0.90  0.16
b
 0.03  0.01
c
 3.44  0.17ª 
C18:2 t10,c12 0.05  0.03
b
 0.04  0.01
b
 0.04  0.01
b
 0.16  0.01ª 
C18:2 CLA cc1 0.01  0.01
c
 0.03  <0.01
b
 0.01  <0.01
c
 0.08  <0.01ª 
C18:2 CLA cc2 0.01  0.01 0.01  <0.01 0.01  <0.01 ND 
C18:2 CLA t,t 0.04  0.03
c
 0.13  <0.01
b
 0.03  0.01
c
 0.51  0.03ª 
 CLA 0.14  0.09
c
 1.11  0.17
b
 0.11  0.04
c
 4.19  0.21ª 
 FA 4.87  0.56
b
 5.50  1.02
b
 3.97  1.21
c
 19.23  0.96ª 
* Average value ± standard deviation. 
a, b, c - Different superscript letters for significant differences (p<0.05) between absence 
vs. presence of LA. 
c = cis double bound; t = trans double bound; cyc = cyclopropane fatty acid; ∑ = total; 
CLA = conjugated linoleic acid; FA = fatty acids; ND = not detected. 
 
The results obtained for B. lactis B94 are shown in Table 3.7. Its pellet revealed a 
significant reduction (p<0.05) of C18:1 c11 and cyc 19:0(c11) in the presence of LA at both 
incubation times, while C4 was increased. When LA was added to the growth medium, the 
level of C16 in the pellet was significantly enhanced, especially after 48 h where values were 
two-fold greater. Results also show an accumulation of LA (C18:2 c9,c12) in the strain’s 
pellet, which content was considerably higher (p<0.05) after 48 h. These differences account 
for the fact that total FA content was considerably higher after 48 h of incubation in the 
presence of LA (7.15 µg/mg). Nonetheless, the same trend was not observed for total CLA 
content, which besides being of very low magnitude (in comparison to CLA content reported 
for B. breve NCIMB 702258; Table 3.6) was significantly higher after 48 h without the 




Table 3.7 Fatty acids composition (µg/mg) of B. lactis B94 pellet after 24 and 48 h of 
incubation in the absence (LA-) and presence (LA+) of LA added to the pre-inocula (0.05 
mg/mL) and inocula (0.5 mg/mL). 
 Incubation time 
 24 h 48 h 
Fatty acid* LA- LA+ LA- LA+ 
C4 0.09  0.04
b
 0.18  0.08ª 0.15  <0.01
b
 0.24  0.06ª 
C14 0.10  0.04 0.11  0.05 0.15  0.01 0.17  0.05 
C16 0.41  0.17
d
 0.94  0.44
b
 0.68  0.02
c
 1.36  0.33ª 
C18 0.07  0.03
b
 0.08  0.04
b
 0.13  0.01ª 0.12  0.02
ab
 
C18:1 c9 0.87  0.34
b
 0.70  0.34
b
 1.61  0.03ª 1.18  0.21
ab
 
C18:1 c11 0.56  0.23ª 0.09  0.03
b
 0.86  0.02ª 0.14  0.02
b
 
C18:2 c9,c12 0.01  <0.01
c
 1.21  0.61
b
 0.02  <0.01
c
 2.66  0.51ª 
cyc 19:0(c9) 0.68  0.28
b
 0.76  0.38
b
 1.06  0.02
ab
 1.14  0.28ª 
cyc 19:0(c11) 0.11  0.04ª 0.02  0.01
b
 0.16  <0.01ª 0.02  0.01
b
 
C18:2 c9,t11 0.02  0.01 0.02  0.01 0.03  <0.01 0.03  <0.01 
C18:2 t10,c12 0.02  0.01
b
 0.02  0.01
b
 0.04  <0.01ª 0.04  <0.01ª 
C18:2 CLA cc1 0.01  <0.01 0.01  <0.01 0.01  <0.01 0.01  <0.01 
C18:2 CLA cc2 0.01  <0.01 0.01  0.01 0.02  <0.01 0.01  <0.01 
C18:2 CLA t,t 0.02  0.01
b
 0.02  <0.01
b
 0.05  <0.01ª 0.02  <0.01
b
 
 CLA 0.07  0.03
b
 0.08  0.03
b
 0.15  <0.01ª 0.11  0.02
b
 
 FA 2.97  0.14
c
 4.17  0.21
b
 4.98  0.10
b
 7.15  1.51ª 
* Average value ± standard deviation. 
a, b, c, d - Different superscript letters for significant differences (p<0.05) between absence 
vs. presence of LA. 
c = cis double bound; t = trans double bound; cyc = cyclopropane fatty acid; ∑ = total; 
CLA = conjugated linoleic acid; FA = fatty acids. 
 
Significant amounts (p<0.05) of LA (18:2 c9,c12) were detected in the L. brevis D24 pellet 
when LA was added to the culture medium (Table 3.8). However, other fatty acids were 
significantly reduced in the presence of LA, such as C16, C18:1 c9, C18:1 c11, cyc 19:0(c9) 
and cyc 19:0(c11). Total CLA level, although little, was significantly lower in the presence of 
LA, independently of the incubation time, and total FA content was not significantly different 







Table 3.8 Fatty acids composition (µg/mg) of L. brevis D24 pellet after 24 and 48 h of 
incubation in the absence (LA-) and presence (LA+) of LA added to the pre-inocula (0.05 
mg/mL) and inocula (0.5 mg/mL). 
 Incubation time 
 24 h 48 h 
Fatty acid* LA- LA+ LA- LA+ 
C4 0.17  0.04 0.22  0.04 0.16  0.01 0.19  0.01 
C14 0.11  0.03 0.07  <0.01 0.10  <0.01 0.05  0.01 
C16 1.14  0.31ª 0.55  0.16
b
 1.10  0.04ª 0.53  0.01
b
 
C18 0.09  0.03 0.07  0.02 0.10  0.01 0.07  <0.01 
C18:1 c9 0.77  0.22ª 0.58  0.20
b
 0.88  0.04ª 0.54  <0.01
b
 
C18:1 c11 0.42  0.12ª 0.11  0.03
b
 0.40  0.02ª 0.09  0.01
b
 
C18:2 c9,c12 0.06  0.02
b
 2.90  0.87ª 0.06  <0.01
b
 2.72  0.01ª 
cyc 19:0(c9) 1.84  0.50ª 0.96  0.30
b
 1.75  0.09ª 0.86  <0.01
b
 
cyc 19:0(c11) 0.55  0.15ª 0.02  <0.01
b
 0.51  0.04
a
 0.03  <0.01
b
 
C18:2 c9,t11 0.05  0.01 0.02  0.01 0.05  <0.01 0.02  <0.01 
C18:2 t10,c12 0.07  0.01 0.03  0.01 0.07  <0.01 0.02  <0.01 
C18:2 CLA cc1 0.01  <0.01 0.01  <0.01 0.01  <0.01 ND 
C18:2 CLA cc2 0.02  <0.01 0.01  0.01 0.02  <0.01 ND 
C18:2 CLA t,t 0.04  <0.01 0.02  <0.01 0.05  <0.01 0.02  <0.01 
 CLA 0.19  0.03
a
 0.09  0.02
b
 0.19  0.01
a
 0.07  0.01
b
 
 FA 5.34  1.44 5.57  1.64 5.26  0.25 5.14  0.01 
* Average value ± standard deviation. 
a, b - Different superscript letters for significant differences (p<0.05) between absence vs. 
presence of LA. 
c = cis double bound; t = trans double bound; cyc = cyclopropane fatty acid; ∑ = total; 
CLA = conjugated linoleic acid; FA = fatty acids; ND = not detected. 
 
The results of L. plantarum 299v pellet analysis (Table 3.9) showed a significant reduction 
(p<0.05) of C14 after 24 h of incubation and of C18:1 c9, C18:1 c11 and cyc 19:0(c9) at both 
incubation times in the presence of LA, whereas C4 was increased. The C16 and LA (C18:2 
c9,c12) contents were considerably enhanced (p<0.05) in the presence of LA, principally after 
48 h of incubation, accounting for the higher total FA content after 48 h in the presence of LA 
(7.83 µg/mg). The total CLA content detected was not significantly different between 








Table 3.9 Fatty acids composition (µg/mg) of L. plantarum 299v pellet after 24 and 48 h of 
incubation in the absence (LA-) and presence (LA+) of LA added to the pre-inocula (0.05 
mg/mL) and inocula (0.5 mg/mL). 
 Incubation time 
 24 h 48 h 
Fatty acid* LA- LA+ LA- LA+ 
C4 0.13  0.02
b
 0.20  0.03ª 0.15  0.02
b
 0.27  0.02ª 
C14 0.14  0.01ª 0.08  0.02
b
 0.16  0.02ª 0.13  0.02ª 
C16 0.52  0.02
d
 0.84  0.17
b
 0.62  0.09
c
 1.07  0.06ª 
C18 0.07  0.01
b
 0.06  0.02
b
 0.09  0.02ª 0.09  0.02ª 
C18:1 c9 1.37  0.04ª 0.72  0.10
c
 1.79  0.26ª 1.09  0.04
b
 
C18:1 c11 0.16  <0.01
b
 0.11  0.01
d
 0.20  0.03ª 0.14  <0.01
c
 
C18:2 c9,c12 0.03  <0.01
c
 2.81  0.48
b
 0.04  0.01
c
 3.66  0.47ª 
cyc 19:0(c9) 1.34  0.02ª 0.96  0.19
b
 1.57  0.23ª 1.19  0.06
b
 
cyc 19:0(c11) 0.03  <0.01 0.04  <0.01 0.03  <0.01 0.04  0.02 
C18:2 c9,t11 0.05  <0.01 0.03  0.01 0.07  0.01 0.05  <0.01 
C18:2 t10,c12 0.04  <0.01 0.04  0.01 0.05  0.01 0.05  <0.01 
C18:2 CLA cc1 0.01  <0.01 0.01  <0.01 0.01  <0.01 0.01  <0.01 
C18:2 CLAcc2 0.02  0.01 0.02  <0.01 0.03  <0.01 0.02  0.01 
C18:2 CLA t,t 0.04  <0.01 0.03  <0.01 0.04  <0.01 0.03  0.01 
 CLA 0.16  0.02 0.13  0.02 0.20  0.03 0.16  <0.01 
 FA 3.95  0.13
c
 5.94  1.04
b
 4.83  0.70
b
 7.83  0.70ª 
* Average value ± standard deviation. 
a, b, c - Different superscript letters for significant differences (p<0.05) between absence 
vs. presence of LA. 
c = cis double bound; t = trans double bound; cyc = cyclopropane fatty acid; ∑ = total; 
CLA = conjugated linoleic acid; FA = fatty acids. 
 
In general, when evaluating the results from the pellets’ analysis, it is possible to conclude 
that there was an accumulation of LA in all strains, especially after 48 h of incubation in most 
cases. This may support the idea made previously (section 3.3) that the strains are absorbing 
the LA added as a previous step to its isomerization into CLA isomers or alternative 
metabolic conversion. 
On overall, the presence of LA also caused standard changes in certain FA contents, 
namely, C16 that was systematically enhanced (with exception of L. brevis D24) and C18:1 
c11 that was consistently reduced, and so were cyc C19:0(9c) (except for B. lactis B94) and 
cyc C19:0(11c). The level of C18:1 c9 was also always affected when LA was present, 




In some cases, the total content of CLA isomers was enhanced when LA was added, 
principally after 48 h, so part of the isomers produced could have been absorbed. The highest 
levels of CLA isomers (about 20 to 40 times higher) were detected in B. breve NCIMB 
702258, as expected. The way CLA could be incorporated is unknown, but according to 
Ogawa et al. (2001) CLA is accumulated as intracellular or cell-associated lipids in free form, 
making it possible for bacteria itself to use it as a CLA source, however, in this case, that 
would not be viable as the amount of CLA released to the culture medium was much higher. 
In what concerns L. brevis D24 its CLA content was reduced in the presence of LA. What 
happened to the natural CLA of this strain is unknown, but the fact is that L. brevis D24 was 
really not able to produce any amount of CLA isomers, corroborated through the supernatant 
analysis.  
In what concerns the total FA content, overall it was enhanced in the presence of LA, 
especially after 48 h, mostly due to the LA accumulated over time. 
Taking into account the results obtained from the supernatant and pellets’ analyses, it was 
concluded that the strategy undertaken in this experiment did not improve CLA production. 
Once more, the results suggested that LA could be being transformed into other unknown 
compounds, as the amount of LA absorbed (in the pellet) did not correspond to the 
percentages of LA reduction (in the supernatant) verified. 
 
3.3.2. Addition of LA after 7 h of incubation 
 
As explained in section 3.3.1, two strategies were undertaken in order to tentatively 
improve CLA production using B. animalis subsp. lactis Bb12, B. breve NCIMB 702258, B. 
lactis B94, L. brevis D24 and L. plantarum 299v. In the second strategy the LA was only 
added after 7 h of incubation to minimize the growth inhibition caused by the addition of LA 
immediately after the inoculation of the strains (Gorissen et al., 2010, 2011) and to guarantee 
that LA is added during a good CLA-producing growth phase, since Van Nieuwenhove et al. 
(2007) observed with dairy bacteria that LA isomerization initiated after the first 4-7 h of 
incubation and other authors (Coakley et al., 2003; Park et al., 2009) demonstrated for 
bifidobacteria strains that CLA formation occurred during the logarithmic to early stationary 







Figure 3.9 Bacterial growth of B. animalis subsp. lactis Bb12 (a), B. breve NCIMB 702258 
(b), B. lactis B94 (c), L. brevis D24 (d) and L. plantarum 299v (e) at 0, 24 and 48 h in the 
absence () and presence () of LA (0.5 mg/mL) added after 7 h of incubation. Results are 
expressed in log (CFU/mL). 
* No significant growth was detected. 
 
No significant differences (p>0.05) in viable cell numbers were detected between 0, 24 and 
48 h of incubation for all five strains tested (Figure 3.9), independently of the presence or the 
absence of LA, with exception of B. breve NCIMB 702258, where after 48 h of incubation no 








absence of LA, bacterial growth tended to be higher after 24 h for all strains but L. brevis D24 
whose cell counts were similar between incubation times. 
Although, in this experiment, LA was only added after 7 h of incubation, there was no 
improvement on bacterial growth. In fact, comparing to the results obtained in section 3.3.1, 
where LA was added during pre-inocula preparation, after 24 h bacterial behavior in the 
presence of LA was similar for both B. breve NCIMB 702258 and L. brevis D24. Viable cell 
numbers reported in section 3.3.1 were of 7.85 and 7.97 log (CFU/mL) and in this experiment 
were of 7.84 and 7.26 log (CFU/mL) for B. breve NCIMB 702258 and L. brevis D24, 
respectively. However, in the case of B. lactis B94, B. animalis subsp. lactis Bb12 and L. 
plantarum 299v, viable cell numbers were reduced from 9.10, 8.58 and 8.17 log (CFU/mL) to 
7.84, 7.47 and 7.61 log (CFU/mL), respectively. Rosberg-Cody et al. (2007) observed with a 
L. lactis strain that even at an advanced growth stage, the strain still showed sensibility to LA, 
so no matter at what point LA is added bacteria will always be affected by the presence of this 
fatty acid. This second strategy showed to not be truly effective and when comparing the 
results, the first strategy (section 3.3.1) showed a better scenario as far as bacterial growth is 
concerned, so LA should keep being added at least at the beginning of the incubation of the 
inocula. 
 
Table 3.10 LA reduction (%) and CLA formation (µg/mL) by selected strains grown in the 
presence of LA (0.5 mg/mL) added after 7 h of incubation in the culture supernatant collected 
after 24 and 48 h of incubation. 
Strain Incubation time (h) LA reduction (%)* CLA (µg/mL)* 
B. animalis subsp. lactis 
Bb12 
24 44.00  1.33 ND 
48 48.87  3.46 ND 
B. breve NCIMB 702258 
24 46.69  1.77
b
 84.30  8.76ª 
48 56.67  2.39ª 56.55  5.39
b
 
B. lactis B94 
24 37.66  2.54 ND 
48 42.42  1.47 ND 
L. brevis D24 
24 46.49  2.53 ND 
48 49.83  2.12 ND 
L. plantarum 299v 
24 34.74  2.85 ND 
48 41.57  3.16 ND 
* Average value ± standard deviation.  
a, b - Different superscript letters for significant differences (p<0.05) between 24h vs. 48 h. 





The analysis of the collected supernatants (Table 3.10) showed an overall LA reduction 
above 34%, being significantly higher (p<0.05) after 48 h for B. breve NCIMB 702258. For 
the remaining strains the values were just slightly higher after 48 h (Table 3.10). In this 
experiment, only B. breve NCIMB 702258 was able to produce CLA at detectable levels. 
Moreover, the production of B. breve NCIMB 702258 was reduced to half of the amount 
obtained through the first strategy, ranging from 56.55 µg/mL at 48 h to 84.30 µg/mL at 24 h, 
being C18:2 c9,t11 the major isomer produced (its corresponding peaks can be seen in the 
chromatograms of Figure 3.10). Therefore, CLA production was not improved through this 
second strategy, and even LA reduction percentages were lower (34.74-56.67%) when 
comparing with the results obtained before in the experiments of optimization of bacterial 
growth conditions (section 3.1) (51.28-69.28%), of CLA production by selected strains 
(section 3.3) (40.36-71.14%) and even of the first strategy (section 3.3.1) (31.97-65.25%). 
For the reasons explained at the beginning of this section, LA was added during the best 
CLA-producing growth phase, which corresponds to a bacterial stage of highest cell density. 
Hennessy et al. (2009) observed with B. breve NCIMB 702258 that a high cell density leads 
to an increased isomerization capacity, but according to Gorissen et al. (2012a) a fast growth 
is no guarantee for a good conversion of LA into CLA for all strains. In our study, it is 
possible that the addition of LA only after 7 h of incubation could have provoked an abrupt 
exposure of this fatty acid to the strains. The initial exposure to LA provided in the previous 
experiments seems to be essential for the strains, because, even if CLA production was not 
considerable, with exception of B. breve NCIMB 702258, at least they were able to produce 
CLA isomers, while in this experiment CLA was not detected at all. Therefore, taking into 
account CLA production and also bacterial growth results from both strategies, LA began to 
















Figure 3.10 Chromatogram profile assessed by gas chromatography of the fatty acids present 
in the culture supernatant of B. breve NCIMB 702258 grown for 24 (a) and 48 h (b) with LA 
(0.5 mg/mL) added after 7 h of incubation. 
  
Regarding B. animalis subsp. lactis Bb12 pellet after growth (Table 3.11), in the presence 
of LA there was a significant increase (p<0.05) of C16, C18, C18:1 c9 and C18:1 c11 at both 
incubation times. Cyc 19:0(c9) level was significantly higher after 24 h in the presence of LA. 
Linoleic acid (18:2 c9,c12) was detected in the strain’s pellet when LA was added to the 
culture medium and its amount was significantly higher after 48 h. The content of CLA 
isomers such as C18:2 c9,t11 and C18:2 t10,c12 increased considerably (p<0.05) in the 




Total FA content was significantly higher at both incubations times in the presence of added 
LA (7.03 µg/mg at 24 h and 7.61 µg/mg at 48 h). 
 
Table 3.11 Fatty acids composition (µg/mg) of B. animalis subsp. lactis Bb12 pellet grown 
for 24 and 48 h in the absence (LA-) and presence (LA+) of LA (0.5 mg/mL) added after 7 h 
of incubation. 
 Incubation time 
 24 h 48 h 
Fatty acid* LA- LA+ LA- LA+ 
C14 0.09  <0.01 0.15  0.02 0.10  0.02 0.13  <0.01 
C16 0.40  0.01
b
 0.70  0.06ª 0.50  0.10
b
 0.71  0.06ª 
C18 0.09  0.01
b
 0.18  0.01ª 0.11  0.02
b
 0.20  0.03ª 
C18:1 c9 0.71  <0.01
b
 1.95  0.23ª 1.01  0.23
b
 2.17  0.19ª 
C18:1 c11 0.67  0.01
b
 1.03  0.11ª 0.78  0.16
b
 1.01  0.10ª 
C18:2 c9,c12 ND
c




 2.17  0.22ª 
cyc 19:0(c9) 0.68  0.01
b
 0.91  0.09ª 0.80  0.19ª 0.86  0.06ª 
cyc 19:0(c11) 0.18  0.01 0.19  0.02 0.21  0.05 0.18  0.01 
C18:2 c9,t11 0.01  <0.01
c
 0.04  <0.01
b
 0.02  <0.01
c
 0.06  <0.01ª 
C18:2 t10,c12 0.01  <0.01
b
 0.05  <0.01ª 0.02  <0.01
b
 0.05  <0.01ª 
C18:2 CLA cc1 0.01  <0.01 0.01  <0.01 0.01  <0.01 0.01  <0.01 
C18:2 CLA cc2 0.01  <0.01 0.02  <0.01 0.01  <0.01 0.01  <0.01 
C18:2 CLA t,t 0.02  <0.01 0.04  0.01 0.02  <0.01 0.06  0.01 
 CLA 0.05  <0.01
c
 0.16  <0.01ª 0.08  0.01
b
 0.19  0.02ª 
 FA 2.87  0.04
c
 7.03  0.71
a
 3.59  0.77
b
 7.61  0.68ª 
* Average value ± standard deviation. 
a, b, c - Different superscript letters for significant differences (p<0.05) between absence 
vs. presence of LA. 
c = cis double bound; t = trans double bound; cyc = cyclopropane fatty acid; ∑ = total; 
CLA = conjugated linoleic acid; FA = fatty acids; ND = not detected. 
 
The presence of added LA caused a significant increment (p<0.05) of C18:1 c9 and C18:1 
c11 in B. breve NCIMB 702258 pellet (Table 3.12) after 24 and 48h. When LA was added to 
the culture medium, LA (C18:2 c9,c12) was detected in the strain’s pellet. CLA isomers 
C18:2 c9,t11, C18:2 t10,c12, and C18:2 CLA t,t were significantly enhanced in the presence 
of LA at both incubation times. Total CLA and FA contents were significantly higher with 
LA being present (0.99 µg/mg at 24 h and 0.93 µg/mg at 48 h for total CLA; 7.24 µg/mg at 24 






Table 3.12 Fatty acids composition (µg/mg) of B. breve NCIMB 702258 pellet grown for 24 
and 48 h in the absence (LA-) and presence (LA+) of LA (0.5 mg/mL) added after 7 h of 
incubation. 
 Incubation time 
 24 h 48 h 
Fatty acid* LA- LA+ LA- LA+ 
C14 0.16  0.03 0.29  0.01 0.20  0.04 0.29  0.04 
C16 1.16  0.25 1.55  0.03 1.42  0.30 1.59  0.21 
C18 0.30  0.07 0.37  0.01 0.36  0.08 0.38  0.06 
C18:1 c9 1.39  0.28
b
 2.15  0.07ª 1.71  0.31
ab
 2.23  0.20ª 
C18:1 c11 0.08  0.02
b
 0.17  0.01ª 0.11  0.02
b
 0.17  0.04ª 
C18:2 c9,c12 ND
b
 1.55  0.08ª ND
b
 1.73  0.19ª 
cyc 19:0(c9) 0.21  0.02 0.16  0.01 0.27  0.05 0.16  0.01 
C18:2 c9,t11 0.02  <0.01
b
 0.71  0.15ª 0.03  <0.01
b
 0.65  0.09ª 
C18:2 t10,c12 0.03  0.01
b
 0.06  <0.01ª 0.03  0.01
b
 0.06  <0.01ª 
C18:2 CLA cc1 0.01  <0.01 0.02  <0.01 0.01  <0.01 0.02  <0.01 
C18:2 CLA cc2 0.01  <0.01 0.01  <0.01 0.02  <0.01 0.01  <0.01 
C18:2 CLA t,t 0.03  0.01
b
 0.19  0.03ª 0.04  0.01
b
 0.18  0.04ª 
 CLA 0.09  0.01
b
 0.99  0.20ª 0.13  0.02
b
 0.93  0.13ª 
 FA 3.40  0.69
b
 7.24  0.25ª 4.20  0.83
b
 7.50  0.86ª 
* Average value ± standard deviation. 
a, b, c,- Different superscript letters for significant differences (p<0.05) between absence 
vs. presence of LA. 
c = cis double bound; t = trans double bound; cyc = cyclopropane fatty acid; ∑ = total; 
CLA = conjugated linoleic acid; FA = fatty acids; ND = not detected. 
 
In what concerns to B. lactis B94 pellet (Table 3.13), the presence of the substrate lead to a 
significant reduction of cyc 19:0(c11) at both incubation times, while C16, C18 and C18:1 c9 
were considerably increased (p<0.05) after 48 h. Amounts of LA (C18:2 c9,c12) were 
detected in strain’s pellet, being the value considerably higher after 48 h. Total amount of 
CLA isomers was not significantly different (p>0.05) between incubation times and 
presence/absence of LA (0.19-0.27 µg/mg), but total FA content was significantly higher with 










Table 3.13 Fatty acids composition (µg/mg) of B. lactis B94 pellet grown for 24 and 48 h in 
the absence (LA-) and presence (LA+) of LA (0.5 mg/mL) added after 7 h of incubation. 
 Incubation time 
 24 h 48 h 
Fatty acid* LA- LA+ LA- LA+ 
C14 0.43  0.09 0.43  0.05 0.49  0.12 0.52  0.01 
C16 0.79  0.14
b
 0.72  0.03
b
 0.92  0.25
ab
 0.93  0.05ª 
C18 0.13  0.02
c
 0.19  0.03
b
 0.18  0.07
bc
 0.25  0.04ª 
C18:1 c9 0.93  0.16
c
 1.47  0.04
b
 1.08  0.26
b
 2.01  0.05ª 
C18:1 c11 0.24  0.04 0.19  0.01 0.28  0.08 0.24  <0.01 
C18:2 c9,c12 ND
c




 3.06  0.22ª 
cyc 19:0(c9) 1.73  0.34
b
 1.74  0.12
b
 2.00  0.44ª 2.15  0.02ª 
cyc 19:0(c11) 0.13  0.02ª 0.04  <0.01
b
 0.15  0.04ª 0.05  <0.01
b
 
C18:2 c9,t11 0.06  0.01 0.06  0.01 0.07  0.02 0.07  <0.01 
C18:2 t10,c12 0.05  0.01 0.06  <0.01 0.06  0.01 0.07  <0.01 
C18:2 CLA cc1 0.01  <0.01 0.01  <0.01 0.02  0.01 0.02  <0.01 
C18:2 CLA cc2 0.02  <0.01 0.02  <0.01 0.02  0.01 0.02  <0.01 
C18:2 CLA t,t 0.05  0.02
b
 0.06  <0.01
b
 0.05  0.02
b
 0.09  <0.01ª 
 CLA 0.19  0.05 0.20  <0.01 0.23  0.07 0.27  0.01 
 FA 4.56  0.87
c
 7.08  0.23
b
 5.33  1.34
c
 9.48  0.41ª 
* Average value ± standard deviation. 
a, b, c - Different superscript letters for significant differences (p<0.05) between absence 
vs. presence of LA. 
c = cis double bound; t = trans double bound; cyc = cyclopropane fatty acid; ∑ = total; 
CLA = conjugated linoleic acid; FA = fatty acids; ND = not detected. 
 
In the case of L. brevis D24 pellet (Table 3.14), C18:1 c9 was considerably increased 
(p<0.05) in the presence of LA at both incubation times. Results show the detection of LA 
(C18:2 c9,c12) when the substrate was present. No significant differences (p>0.05) were 
found among the total CLA content, ranging from 0.13 to 0.19 µg/mg, but total FA was 












Table 3.14 Fatty acids composition (µg/mg) of L. brevis D24 pellet grown for 24 and 48 h in 
the absence (LA-) and presence (LA+) of LA (0.5 mg/mL) added after 7 h of incubation. 
 Incubation time 
 24 h 48 h 
Fatty acid* LA- LA+ LA- LA+ 
C14 0.10  0.01 0.11  0.02 0.10  0.01 0.10  0.01 
C16 1.07  0.23 1.15  0.21 1.14  0.03 1.12  0.08 
C18 0.12  0.02 0.16  0.04 0.14  0.01 0.16  0.01 
C18:1 c9 0.59  0.14
c
 0.94  0.17ª 0.77  0.02
b
 0.94  0.07ª 
C18:1 c11 0.40  0.09 0.44  0.07 0.43  0.01 0.43  0.02 
C18:2 c9,c12 ND
b
 1.80  0.48ª ND
b
 1.81  0.12ª 
cyc 19:0(c9) 1.46  0.30 1.55  0.29 1.55  0.04 1.51  0.13 
cyc 19:0(c11) 0.49  0.11 0.43  0.08 0.51  0.01 0.41  0.03 
C18:2 c9,t11 0.04  0.01 0.05  0.01 0.04  <0.01 0.05  <0.01 
C18:2 t10,c12 0.05  0.01 0.06  0.01 0.05  <0.01 0.06  <0.01 
C18:2 CLA cc1 0.01  0.01 0.01  <0.01 0.01  <0.01 0.01  <0.01 
C18:2 CLA cc2 0.01  0.01 0.01  <0.01 0.01  <0.01 0.01  <0.01 
C18:2 CLA t,t 0.03  <0.01 0.06  0.01 0.05  0.02 0.06  0.01 
 CLA 0.13  0.04 0.19  0.04 0.16  0.02 0.19  0.01 
 FA 4.35  0.95
b
 6.77  1.40
a
 4.80  0.15
b
 6.68  0.48ª 
* Average value ± standard deviation. 
a, b, c - Different superscript letters for significant differences (p<0.05) between absence 
vs. presence of LA. 
c = cis double bound; t = trans double bound; cyc = cyclopropane fatty acid; ∑ = total; 
CLA = conjugated linoleic acid; FA = fatty acids; ND = not detected. 
 
Concerning to L. plantarum 299v pellet (Table 3.15), the presence of LA in the culture 
medium caused a significant increase of C16. Linoleic acid (C18:2 c9,c12) was detected in 
the strain’s pellet when the substrate was present. Total CLA amount was not significantly 
different (p>0.05) between the situations tested (0.13-0.18 µg/mg), while the level of total FA 
was considerably higher (p<0.05) in the presence of LA (6.23 µg/mg at 24 h and 6.61 µg/mg 











Table 3.15 Fatty acids composition (µg/mg) of L. plantarum 299v pellet grown for 24 and 48 
h in the absence (LA-) and presence (LA+) of LA (0.5 mg/mL) added after 7 h of incubation. 
 Incubation time 
 24 h 48 h 
Fatty acid* LA- LA+ LA- LA+ 
C14 0.14  0.01 0.15  0.01 0.15  0.01 0.16  0.04 
C16 0.49  0.04
b
 0.72  0.05ª 0.53  0.03
b
 0.77  0.14ª 
C18 0.11  <0.01 0.16  0.02 0.13  0.01 0.18  <0.01 
C18:1 c9 1.28  0.11 1.60  0.12 1.50  0.11 1.71  0.27 
C18:1 c11 0.16  0.01 0.16  0.01 0.18  0.01 0.17  0.03 
C18:2 c9,c12 ND
b
 2.17  0.18ª ND
b
 2.27  0.40ª 
cyc 19:0(c9) 1.27  0.13 1.07  0.07 1.34  0.12 1.13  0.20 
cyc 19:0(c11) 0.02  <0.01 0.03  <0.01 0.02  <0.01 0.04  0.01 
C18:2 c9,t11 0.04  <0.01 0.05  <0.01 0.05  <0.01 0.06  0.02 
C18:2 t10,c12 0.03  <0.01 0.04  <0.01 0.04  <0.01 0.04  0.01 
C18:2 CLA cc1 0.01  <0.01 0.01  <0.01 0.01  <0.01 0.01  <0.01 
C18:2 CLA cc2 0.02  <0.01 0.02  <0.01 0.02  <0.01 0.02  0.01 
C18:2 CLA t,t 0.03  0.01 0.04  <0.01 0.04  <0.01 0.05  <0.01 
 CLA 0.13  0.01 0.16  0.01 0.16  0.01 0.18  0.03 
 FA 3.62  0.31
b
 6.23  0.47
a
 4.03  0.30
b
 6.61  1.11ª 
* Average value ± standard deviation. 
a, b - Different superscript letters for significant differences (p<0.05) between absence vs. 
presence of LA. 
c = cis double bound; t = trans double bound; cyc = cyclopropane fatty acid; ∑ = total; 
CLA = conjugated linoleic acid; FA = fatty acids; ND = not detected. 
 
Evaluating the results from the pellets’ analysis, once more the accumulation of LA was 
observed when such substrate was added to the culture medium, being that value higher after 
48 h of incubation for two of the three Bifidobacterium strains tested (i.e. B. animalis subsp. 
lactis Bb12 and B. lactis B94). These results strengthen the hypothesis made from the results 
of the previous experiments (sections 3.3 and 3.3.1), i.e. LA may be absorbed to be further 
converted into CLA isomers or other unknown compounds.  
Similar to the first strategy (section 3.3.1), in this experiment there was a standard group of 
certain fatty acids that were generally affected by the presence of LA, namely C16, C18, 
C18:1 c9 and C18:1 t11, whose values were enhanced. In the first strategy, C19:0(c9) was, in 
general, reduced when the substrate was added to the culture medium. However, in this 
experiment, it was not found a standard for the way C19:0(c9) was affected. C19:0(c11) was 




Concerning to total CLA content, B. breve NCIMB 702258 revealed higher levels when 
LA was present. Therefore, as in the first strategy, part of the CLA isomers produced were 
probably absorbed by this strain. However, a substantial amount of CLA continues to be 
detected in the supernatant. No significant changes (p>0.05) on total CLA were observed for 
B. lactis B94, L. brevis D24 and L. plantarum 299v, but no CLA isomers were detected in the 
supernatant also. On the other hand, B. animalis subsp. lactis Bb12, which was also not able 
to produce CLA at detectable levels in the supernatant, revealed significantly higher amounts 
of total CLA when LA was present. The possible explanation for this fact is that all LA 
converted by this strain was absorbed instead of being released to the medium. 
Total FA was considerably higher in the presence of LA for all strains, due to the 
accumulation of the substrate and the associated increment of the fatty acids mentioned 
above. 
Regarding the results from supernatants and pellets’ analysis, it is possible to conclude that 
none of the strategies applied have improved CLA production; indeed, the values from the 
second strategy were even worse than the first one. If the strains are only able to produce 
other compounds than CLA, then no matter what strategy it is applied no improvement in 
CLA production will be seen. 
Despite the failure in CLA production optimization, a CLA-producer strain, B. breve 
NCIMB 702258, was found. Therefore, this strain was selected for further studies concerning 
the potential CLNA production. 
 
3.4. CLA and CLNA production with Bifidobacterium breve NCIMB 702258 
 
Among the strains tested in this study, B. breve NCIMB 702258 showed the capacity to 
convert LA into CLA isomers, therefore the following step was to investigate whether this 
strain could also produce CLNA isomers. Thus, the strain was grown for 24 h in the presence 








Figure 3.11 Bacterial growth of B. breve NCIMB 702258 at 0 and 24 h of incubation in the 
absence () and presence of 0.5 mg/mL of -LNA (), -LNA ( ) and LA+-LNA+-LNA 
(1:1:1) ( ) when grown in cys-MRS medium. Results are expressed in log (CFU/mL). 
Different letters for significant differences (p<0.05) between 0 h vs. 24 h. 
 
After 24 h of incubation, the number of B. breve NCIMB 702258 viable cells was 
significantly higher (p<0.05) in the absence of substrate (9.19 log (CFU/mL)) (Figure 3.11), 
while in the presence of any of the substrates the values were not significantly different 
(p>0.05), in comparison to those added at the beginning of the incubation (0 h), although in 
the presence of LA+-LNA+-LNA cell numbers tended to be higher after 24 h. Viable cell 
numbers were slightly lowered when the precursor substrates were added to the culture 
medium, specially -LNA. Villar-Tajadura et al. (2014) have also detected some reduction in 
B. breve M7-70 viable cell numbers with 0.5 mg/mL of -LNA, while Gorissen et al. (2010) 
observed that among 36 Bifidobacterium strains, bacterial growth inhibition was only detected 
in 14 of these strains in the presence of 0.5 mg/mL of -LNA. Since the -LNA 
concentration used was always the same, Bidifobacterium strains behavior in the presence of 
-LNA seems to differ according to the strain, as it was previously observed for LA. 
When B. breve NCIMB 702258 was grown with -LNA, 94.96% of this substrate was 
reduced and ca. 293.28 µg/mL of CLNA isomers were detected (data not shown), 
corresponding to C18:3 c9,t11,c15 and C18:3 t9,t11,c15. In the presence of -LNA the 
reduction rate was of 23.48% but no CLNA isomers were detected. When all three substrates 
were present, the reduction percentages were of 26.01% for LA, 72.61% for -LNA and 
18.95% for -LNA, being produced ca. 55.22 µg/mL of CLA (mainly C18:2 c9,t11) and 
207.89 µg/mL of CLNA, corresponding to C18:3 c9,t11,c15 and C18:3 t9,t11,c15. 




the peaks revealed in the corresponding chromatograms presented in Figure 3.12. In the study 
carried out by Coakley et al. (2009), B. breve NCIMB 702258 also produced high amounts of 
CLNA (mostly C18:3 c9,t11,c15) when grown at 37 ºC for 42 h with 0.41 mg/mL of -LNA, 
where the conversion rate was of 79.1%. Similar results were obtained by Hennessy et al. 
(2012) through the incubation of this same strain at 37 ºC for 72 h with 0.45 mg/mL of -
LNA, where it was detected the production of 199 µg/mL of CLNA isomers, corresponding to 
C18:3 c9,t11,c15 and C18:3 t9,t11,c15. However, they were also able to detect, at the same 
conditions, the production of 149 µg/mL of CLNA in the presence of -LNA, while in our 
experiment no isomers were detected using this substrate. 
Comparing these results to those obtained in CLA production with selected strains (section 
3.3), after 24 h, B. breve NCIMB 702258 was able to produce more CLNA (293.28 µg/mL) 
than CLA (155.83 µg/mL), as LNA reduction rate (94.96%) was also higher than that of LA 
(66.13%). Moreover, when the three substrates were added together to the culture medium, 
similar results were observed, i.e. -LNA reduction rate (72.61%) and CLNA concentration 
(207.89 µg/mL) were higher than LA reduction rate (26.01%) and CLA concentration (55.22 
µg/mL). Other studies (Gorissen et al., 2010; Villar-Tajadura et al., 2014) have also detected 
higher conversion rates of LNA than LA when added separately. Jiang et al. (1998) have 
hypothesized that the reaction involved in LA and LNA conversion could be a detoxification 
mechanism of the bacteria. Therefore the results of this experiment suggest that -LNA might 
















Figure 3.12 Chromatogram profile assessed by gas chromatography of the fatty acids present 
in the culture supernatant of B. breve NCIMB 702258 grown for 24 h with 0.5 mg/mL of -











Table 3.16 Fatty acids composition (µg/mg) of B. breve NCIMB 702258 pellet after 24 h of 
incubation in the absence and presence of 0.5 mg/mL of -LNA, -LNA and LA+-LNA+-
LNA (1:1:1). 
 Substrate 
Fatty acid* Absent -LNA -LNA LA+-LNA+-LNA 
C14 0.41  0.02 0.23  0.11 0.09  0.01 0.11  0.04 
C16 1.96  0.05
b
 2.31  0.12ª 1.53  0.08
c
 1.86  0.09
b
 
C18 0.30  0.01 0.21  0.13 0.14  0.01 0.19  0.10 
C18:1 c9 2.08  0.13ª 1.53  0.75ª 0.80  0.04
b
 0.86  0.38
b
 
C18:1 c11 0.14  0.01
b
 0.23  0.14ª 0.09  0.01
c
 0.11  0.04
b
 
C18:2 c9,c12 ND ND ND 0.78  0.37 










 0.23  0.11ª ND
b
 0.24  0.14ª 






 0.23  0.13ª 




 0.05  0.03ª 






 0.09  0.04ª 
C18:3 c6,c9,t11 ND ND ND ND 
C18:3 c6,t9,t11 ND ND ND ND 
C18:3 c9,t11,c15 ND
c













 0.14  0.07
b
 






 0.37  0.19ª 
 CLNA ND
c
 2.04  0.87ª ND
c
 0.69  0.34
b
 
 FA 5.40  0.26ª 6.96  3.35ª 3.63  0.02
b
 5.95  2.84ª 
* Average value ± standard deviation. 
a, b, c - Different superscript letters for significant differences (p<0.05) between absence 
vs. presence of -LNA, -LNA or LA+-LNA+-LNA. 
c = cis double bound; t = trans double bound; cyc = cyclopropane fatty acid; ∑ = total; 
CLA = conjugated linoleic acid; CLNA = conjugated linolenic acid; FA = fatty acids;         
ND = not detected. 
 
As it was seen in the previous experiments (sections 3.3.1 and 3.3.2), the levels of certain 
fatty acids, such as C16, C18:1 c9 and C18:1 c11, were also affected in the presence of the 
substrates tested in this experiment (Table 3.16). Comparing the fatty acid composition values 
of B. breve NCIMB 702258 grown with no substrate, C16 and C18:1 c11 amounts were 
significantly enhanced (p<0.05) in the presence of -LNA, while C18:1 c9 content was not 
different (p>0.05). In the presence of -LNA, the same fatty acids were significantly reduced. 
When the three substrates were added together, no significant alterations in C16 and C18:1 




These results also show an accumulation of each substrate in the strain’s pellet. Since B. 
breve NCIMB 702258 demonstrated the ability to produce CLA and CLNA isomers, such 
absorption must be related to the desintoxification mechanism, as hypothesized by Rosberg-
Cody et al. (2007). 
Comparing the values of B. breve NCIMB 702258 pellet fatty acid composition in the 
absence of substrate, total amount of CLA was significantly increased in the presence of the 
three substrates (0.37 µg/mg) and the total content of CLNA was significantly enhanced in the 
presence of -LNA (2.04 µg/mg). This may suggest that a fraction of the isomers produced 
was absorbed by the strain. However, the majority of CLA and CLNA isomers formed 
continues to be released into the culture medium. The total FA content was not significantly 
different between the conditions tested (5.40-6.69 µg/mg), except when -LNA was added 
individually, where the value was significantly lower (3.63 µg/mg), since not only was there a 
significant reduction of C16, C18:1 c9 and C18:1 c11 but also no CLA and CLNA isomers 
were detected. 
 
3.5. CLA and CLNA production in milk with Bifidobacterium breve NCIMB 702258 
 
Besides CLA, B. breve NCIMB 702258 revealed capacity to produce CLNA isomers. Due 
to CLA and CLNA bioactive potential as functional ingredients, it was of interest to test if B. 
breve NCIMB 702258 could also produce those isomers in a food matrix. Therefore, this 
strain was grown in commercial 1.6% reduced-fat milk for 24 h with either LA, -LNA or 
both substrates.  
 
 
Figure 3.13 Bacterial growth of B. breve NCIMB 702258 at 0 and 24 h of incubation in the 
absence () and presence of 0.5 mg/mL of LA (), -LNA ( ) and LA+-LNA (1:1) ( ) 
when grown in 1.6% reduced-fat milk. Results are expressed in log (CFU/mL). Different 




After 24 h of incubation, there was a significant increase (p<0.05) of more than two log 
cycles in the viable cell numbers of B. breve NCIMB 702258 independently of the absence or 
presence of the different substrates added (cell numbers varied from 6.71-7.05 log (CFU/mL) 
to 9.38-9.47 log (CFU/mL)) (Figure 3.13). Indeed, viable cell numbers after 24 h of 
incubation were similar between all substrate situations tested. Some other studies (Gorissen 
et al., 2012b; Van Nieuwenhove et al., 2007) also observed that the growth of different 
bifidobacteria strains in milk was not affected by the presence of LA and -LNA, when 
comparing to the growth behavior with no substrate added. In the previous experiment 
(section 3.4), where the strain was grown in cys-MRS, it was detected a slight decrease in cell 
numbers in the presence of any substrate. Therefore, milk demonstrated to be a more suitable 
growth medium for this bifidobacteria strain, a somehow expected trait given the protective 
effect of milk protein on bifidobacteria stability and viability (Gomes and Malcata, 1998; 
Madureira et al., 2011). 
 
Table 3.17 Substrate reduction (%) and CLA/CLNA formation (µg/mL) by B. breve NCIMB 
702258 grown in 1.6% reduced-fat milk added with either 0.5 mg/mL of LA, -LNA or both 
substrates (1:1) for 24 h of incubation. 
Substrate Substrate reduction (%)* CLA (µg/mL)* CLNA (µg/mL)* 
LA 45.98  3.89 94.86  6.99 ND 
-LNA 53.76  4.20 ND 114.03  9.40 
LA + -LNA 22.15  0.87 / 28.62  1.48 108.88  5.59 61.01  4.12 
* Average value ± standard deviation. 
ND = not detected. 
 
Evaluating the milk samples collected after 24 h of incubation in the presence of LA 
(Table 3.17), the substrate reduction rate was of 45.98%, being produced 94.86 µg/mL of 
CLA. When -LNA was used as precursor substrate, the percentage of substrate reduction 
was higher (53.76%) as well as the concentration of CLNA isomers formed (114.03 µg/mL), 
which may support the previously mentioned hypothesis that -LNA could be more toxic 
than LA. However, when both substrates were present, the amount of CLA isomers formed 
(108.88 µg/mL) was higher than those of CLNA (61.01 µg/mL). The possible explanation for 
this fact, could be that, in the presence of LA, -LNA is converted to CLA isomers instead of 
CLNA counterparts, as already suggested by other studies (Jouany et al., 2007; Lee and 
Jenkins, 2011; Loor et al., 2005). Figure 3.14 shows the fatty acids peaks revealed for the 




Some studies (Chung et al., 2008; Van Nieuwenhove et al., 2007) were also able to detect 
CLA production with B. bidifum CRL1399 and B. breve LMC 520 in milk based media with 
0.2 mg/mL and 0.5 mg/mL of LA, respectively. After 24 h of incubation at 37 ºC, B. bidifum 
CRL1399 produced 190.2 µg/mL of CLA and B. breve LMC 520 formed 113 µg/mL after 48 
h at 37 ºC. Our research is the first to show microbial production of CLA and CLNA in a food 
matrix in the presence of the corresponding precursor substrates. 
Hennessy et al. (2009) observed that with B. breve NCIMB 702258 the production of CLA 
in a 20% (w/v) reconstituted skim milk was significantly lower than in cys-MRS culture 
medium. Similar results were obtained in our study, for both CLA and CLNA, where under 
the same growth conditions (24 h at 37 ºC with added 0.5 mg/mL of LA or -LNA), the CLA 
amount was reduced from 155.83 µg/mL (section 3.3) to 94.86 µg/mL and CLNA from 
293.23 µg/mL (section 3.4) to 114.03 µg/mL. Therefore, for a future elaboration of CLA- and 
CLNA-enriched foodstuffs, the production in milk will need to be improved.  
Despite the reduction in CLA and CLNA production values in milk, B. breve NCIMB 
702258 demonstrated a great potential for the development of enriched food products. 
However, to obtain an edible product, apart from the sensorial parameters, that need to be 
optimized, the source of LA and -LNA must be other than free fatty acids, since pure LA 
and -LNA are not allowed as food additives, due to their potential toxicity at high levels 
(Roden, 2004; Wyne, 2003). Some studies (Choi et al., 2008; Chung et al., 2008; Xu et al., 
2004) have tested CLA production in milk-based media using esterified LA, however, in most 
cases the concentration of CLA isomers detected was lower than with pure LA or an 
hydrolyzed LA source. Literature studies have included the study of sunflower, canola, castor 
and safflower oils added to milk-based media as source of LA (Kishino et al., 2002a; 













Figure 3.14 Chromatogram profile assessed by gas chromatography of the fatty acids present 
in the cultures of B. breve NCIMB 702258 grown in 1.6% reduced-fat milk for 24 h with 0.5 







Table 3.18 Fatty acids composition (µg/mL) of the 1.6% reduced-fat milk used (control) and of the milk cultured with B. breve NCIMB 702258 
during 24 h in the absence and presence of either 0.5 mg/mL of LA, -LNA or both substrates (1:1). 
 Milk samples 
Fatty acid* Control Strain Strain+LA Strain+-LNA Strain+LA+-LNA 
C4 92.36  0.97
a
 74.99  5.67
bc
 66.61  0.96
c
 70.87  4.70
bc
 79.14  0.20
b
 
C6 107.78  1.50
a
 86.67  7.59
c
 76.80  0.49
d
 82.88  4.62
c
 93.74  0.03
b
 
C8 100.24  0.63
a
 84.06  6.69
bc
 72.43  2.25
d
 77.49  6.13
cd
 85.59  1.18
b
 
C10 314.45  2.25
a
 263.27  24.93
bc
 228.80  3.08
c
 242.19  13.83
c
 273.03  2.12
b
 
C12 433.39  3.28 361.76  36.17 312.61  7.50 332.61  27.71 371.56  3.31 
C14 1549.81  8.32
a
 1307.93  130.74
b
 1127.51  30.98
c
 1197.32  99.76
c
 1339.43  5.80
b
 
C15i 37.18  1.00 31.87  3.24 27.88  0.47 29.35  3.41 31.86  0.99 
C14:1 c9 131.08  2.85
a
 110.01  11.01
bc
 96.03  2.22
c
 102.08  10.33
bc
 112.24  1.27
b
 
C15ai 81.31  1.25
a
 68.75  8.29
bc
 58.34  2.20
c
 62.94  5.81
c
 72.12  0.86
b
 
C15 155.16  0.92
a
 131.87  12.34
bc
 113.33  2.79
c
 121.20  11.68
c
 135.19  0.55
b
 
C16i 43.02  0.26
a
 36.50  3.61
b
 31.95  2.71
c
 34.29  3.72
bc
 37.26  0.49
b
 
C16 4263.39  26.18
a
 3619.49  357.14
bc
 3124.84  83.48
d
 3314.30  284.04
cd
 3719.77  15.52
b
 
C16:1 c9 197.31  3.01ª 166.07  17.19
bc
 143.38  5.43
d
 153.77  13.93
cd
 173.27  1.68
b
 
C17i 53.46  1.38ª 45.39  3.96
b
 38.38  2.81
c
 41.40  4.66
b
 46.57  1.12
b
 
C17ai 89.00  2.82ª 75.72  8.90
bc
 65.57  3.08
d
 69.37  7.17
cd
 79.65  0.02
b
 
C17:1 c10 34.69  2.27ª 29.19  2.68
b
 24.45  0.35
c
 27.95  1.88
b
 30.92  0.38
b
 
C18 1419.67  9.34ª 1202.45  120.57
bc
 1038.38  28.66
d
 1101.99  89.23
cd
 1235.45  2.45
b
 
C18:1 t4 5.44  0.08ª 4.57  0.77ª 3.23  0.14
b
 3.93  0.57
b
 4.95  0.99ª 
C18:1 t5 7.45  1.36 5.49  1.28 6.15  0.11 5.39  0.85 7.08  1.25 
C18:1 t6-t9 76.18  0.75ª 69.61  8.99
ab
 63.99  2.62
b
 62.76  4.93
b
 75.67  0.59ª 
C18:1 t10 55.78  0.99 49.93  6.82 44.51  2.75 45.56  3.74 52.87  1.27 
* Average value ± standard deviation. 
a, b, c, d - Different superscript letters for significant differences (p<0.05) between milk samples. 







Table 3.18 (continued) Fatty acids composition (µg/mL) of the 1.6% reduced-fat milk used (control) and of the milk cultured with B. breve 
NCIMB 702258 during 24 h in the absence and presence of either 0.5 mg/mL of LA, -LNA or both substrates (1:1). 
 Milk samples 
Fatty acid* Control Strain Strain+LA Strain+-LNA Strain+LA+-LNA 
C18:1 t11 213.34  1.84ª 180.80  19.64
bc
 159.57  3.31
d
 164.92  13.97
cd
 188.44  0.23
b
 
C18:1 t12 52.70  1.19ª 44.94  6.56
bc
 40.42  2.29
c
 41.92  2.28
c
 50.20  0.66
ab
 
C18:1 c9 2760.62  21.02ª 2320.69  233.14
b
 2087.81  59.65
c
 2227.76  193.05
b
 2591.34  0.57
b
 
C18:1 t15 28.77  1.00 26.70  5.28 25.65  0.24 25.01  1.16 28.57  1.51 
C18:1 c11 81.85  2.61ª 67.62  8.75
b
 63.50  2.12
b
 66.96  6.53
b
 78.12  2.55ª 
C18:2 c9,c12 219.55  1.09
b
 179.91  18.84
c
 431.38  15.26ª 172.92  11.44
c
 526.62  3.41ª 
C18:2 c9,c15 25.02  1.67ª 19.82  2.64
b
 17.94  1.56
c
 19.04  1.06
b
 20.46  0.55
b
 
cyc 19:0(c9) 8.60  0.03 10.36  1.34 8.04  2.46 8.94  2.16 9.28  1.41 
C18:3 c6,c9,c12 7.74  0.09 7.19  1.14 7.30  1.56 6.83  0.76 6.97  1.14 
C18:3 c9,c12,c15 53.59  1.75
c
 42.88  5.15
d
 37.90  1.45
e
 241.33  17.06
b
 352.83  6.20ª 
C18:2 c9,t11 82.67  2.55ª 61.64  1.26
d
 72.66  5.09
bc
 67.34  7.85
cd
 87.01  4.66ª 
C18:2 t10,c12 3.63  0.64
d
 3.96  1.40
cd
 4.83  0.30
c
 6.33  0.73
b
 11.31  1.52ª 
C18:2 CLA cc1 15.65  0.62 12.51  2.03 11.39  0.63 11.70  0.83 12.88  0.22 
C18:2 CLA cc2 2.44  0.08 2.57  0.31 1.83  0.32 2.84  0.52 2.53  0.03 
C18:2 CLA t,t 12.70  0.49
b
 10.18  0.96
b
 13.81  1.26
b
 11.89  1.92
b
 20.39  0.40ª 
C18:3 c9,t11,c15 4.49  0.24
c
 3.33  0.17
d
 4.02  0.53
c
 106.12  5.83ª 53.86  4.34
b
 
C18:3 t9,t11,c15 2.26  0.83
c
 2.69  0.61
c
 2.71  0.15
c
 9.14  3.56ª 7.71  0.22
b
 
∑ CLA 117.09  4.38
b
 90.87  5.95
c
 104.52  6.99
c
 100.11  11.86
c
 134.13  5.59ª 
∑ CLNA 6.75  0.59
c
 6.03  0.78
c
 6.73  0.68
c
 115.26  9.40ª 61.57  4.12
b
 
∑ FA 12823.80  98.44ª 10823.38  541.17
b
 9755.93  277.33
c
 10370.63  518.53
bc
 12105.89  2.84
a
 
* Average value ± standard deviation. 
a, b, c, d, e - Different superscript letters for significant differences (p<0.05) between milk samples. 
c = cis double bound; t = trans double bound; cyc = cyclopropane fatty acid; ∑ = total; CLA = conjugated linoleic acid; CLNA = conjugated 




Concerning the levels of each fatty acid identified in the milk samples (Table 3.18), it is 
possible to observe that the amount of C4, C6, C8, C10, C14, C14:1 c9, C15ai, C15, c16i, 
C16, C16:1 c9, C17i, C17ai, C17:1 c10, C18: C18:1 t11, C18:1 c9 and C18:2 c9,c15 is 
significantly higher (p<0.05) in the control. The inoculation with B. breve NCIMB 702258 led 
to the lowering of those values, especially when LA was present (Table 3.18). The possible 
explanation could be that the strain is retrieving the energy needed for its growth from those 
fatty acids present in milk. A possibility may be that when LA was added it could have caused 
a more stressful environment for the strain that made it consume more energy. 
It was not possible to separate the supernatant from the pellet, so there is no way to 
discover if the substrates were being absorbed by B. breve NCIMB 702258, as previously 
observed (sections 3.3.1, 3.3.2 and 3.4). Concerning the CLA and CLNA total contents, the 
amount of CLA isomers was significantly higher in milk enriched with both substrates 
(134.13 µg/mL) than with just LA (104.52 µg/mL). However, CLNA concentration was 
almost double the amount in milk enriched with -LNA alone (115.26 µg/mL) than with both 
substrates (61.57 µg/mL). This supports the previously formulated hypothesis: the presence of 
LA favors -LNA conversion to CLA isomers instead of to the CLNA counterparts. 
The total amount of FA was significantly (p<0.05) the highest in the control milk 
(12823.80 µg/mL), since the presence of B. breve NCIMB 702258 resulted in a generally 
lower fatty acid composition. Among the B. breve NCIMB 702258 inoculated milk samples 
those enriched with both precursor substrates contained the highest total FA content 






In order to satisfy the ever-growing consumer demands for healthy functional foods 
capable of promoting well-being and prevent diseases, scientists are in persistent search for 
new functional ingredients. The potential bioactivity of the conjugated fatty acids CLA and 
more recently, CLNA, make them potential candidates even more when theirs in situ 
production may be promoted by adding bacteria able to produce these FA isomers during the 
culture/manufacturing process. In this work, the identification of CLNA-producing strains as 
well as the most favourable growth conditions were studied. 
Based on the results of this research work, in the experimental conditions used, it can be 
concluded that: 
- Molecular screening was demonstrated to be a useful tool in the identification of 
potential producers, yet it has to be further combined with production assays in 
order to test/improve substrate transformation; 
- The precursor substrates added to the culture media were being absorbed into the 
bacteria. The presence of CLA, CLNA or both in the culture supernatant suggests 
that substrate conversion may occur in the membrane and then the resulting 
products are released into the culture medium; 
- Some bacteria that were LAI-gene positive did not show CLA production, 
although the precursor substrate was actually reduced. These results suggest that 
LA was probably being converted into other unexpected compounds, such as 
HFAs. However, since we were not able to detect those compounds, there must 
exist an alternative transformation pathway not yet described; 
- CLA production demonstrated to be dependent on growth conditions and strain as 
not all strains were able to isomerize LA into CLA isomers at considerable levels 
and the changes applied on growth conditions led to different CLA concentration 
values; 
- B. breve NCIMB 702258 was identified as a CLA and a CLNA producer. 
Although it was possible to promote CLA and CLNA production in a food matrix 
such as 1.6% reduced-fat milk, the organoleptic characteristics of the product 





5. Future work 
 
Although the potential of CLA and CLNA producing strains has been demonstrated, 
challenges remain ahead. Concerning the LAI-gene positive strains, it would be of interest in 
the future to verify if this gene is actually being expressed when the strain is grown in the 
presence of the precursor substrate, because, in fact, something in the culture medium could 
be inhibiting its expression preventing the strains from being able to convert the substrate. 
LAI-gene primers are specific according to species and none have been described for 
bifidobacteria strains. Therefore, in order to obtain a high functional screening tool, future 
researches studies could target the sequencing of bifidobacteria LAI-gene for further 
construction of the respective primers. 
Pellets’ analysis demonstrated that the LA added to the cultures medium may be being 
absorbed by the strains, but the way in which it was being incorporated is unknown so it 
would be interesting to investigate in which form LA is accumulated and in which part of the 
cell, whether it be the cytoplasm or the membrane. 
High LA reduction percentages and low CLA production were verified in this work, 
suggesting that the substrate could be being converted into other unknown compounds. 
Therefore, it would be important to identify which compounds were being generated and by 
which alternative transformation pathway of the substrates. 
A further challenge for the future would be the effective elaboration of enriched foodstuffs 
with the identified CLNA-producer B. breve NCIMB 702258, using a safe substrate source 
and optimizing the sensorial parameters of the products. The study of CLNA stability during 
the elaboration and storage of those enriched foodstuffs would also be of interest, in order to 
verify the profitability and viability of the process with respect to CLNA content. Testing the 
bioactivity of those products at the human level would also be interesting to investigate if they 









Table 1.2 CLNA-producing strains, culture growth conditions (medium, [LNA] (mg/mL), temperature (T; ºC) and time (t; h)), LNA conversion 














MRS 63.00 37 72 40.0 
C18:3 c9,t11,c15 
C18:3 t9,t11,c15 
Kishino et al., 2003 
MRS 4.00 37 48 47.0 
C18:3 c9,t11,c15 
C18:3 t9,t11,c15 
Kishino et al., 2009 
Lactobacillus sakei MRS 0.50 30 72 60.1 
C18:3 c9,t11,c15 
C18:3 t9,t11,c15 




BHI 0.02 37 48 




BHI 0.02 37 48 
Propionibacterium 
acidipropionici 
BHI 0.02 37 48 
Propionibacterium 
tecbnicum 










Table 1.2 (continued) CLNA-producing strains, culture growth conditions (medium, [LNA] (µg/mL), temperature (T; ºC) and time (t; h)), LNA 















cys-MRS 0.45 30 72 53.5 
C18:3 c9,t11,c15 
C18:3 t9,t11,c15 





67.6-80.7 C18:3 c9,t11,c15 
C18:3 t9,t11,c15 
Coakley et al., 2009 
0.41 49.4-79.1 
Skim milk 0.50 37 24 94.0-97.0 C18:3 c9,t11,c15 Villar-Tajadura et al., 2014 
cys-MRS 0.50 37 72 55.6-72.0 
C18:3 c9,t11,c15 
C18:3 t9,t11,c15 
Gorissen et al., 2010 
Milk 0.75 37 24 ND ND Gorissen et al., 2012b 
Bifidobacterium 
bifidum 
cys-MRS 0.50 37 72 78.4 
C18:3 c9,t11,c15 
C18:3 t9,t11,c15 
Gorissen et al., 2010 




cys-MRS 0.50 37 72 62.7 
C18:3 c9,t11,c15 
C18:3 t9,t11,c15 
Gorissen et al., 2010 
Milk 0.75 37 24 ND ND Gorissen et al., 2012b 
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